Set Analyses:
Advanced Search

Advanced Search

Search By
Section (entire)

or upload a file of gene symbols

Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21

IL2RB Gene

protein-coding   GIFtS: 67
GCID: GC22M037515

Interleukin 2 Receptor, Beta

(Previous names: interleukin 15 receptor, beta)
(Previous symbol: IL15RB)
Microbiology & Infectious Diseases Congress
  See related diseases

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

Interleukin 2 Receptor, Beta1 2     IL-2R Subunit Beta2 3
IL15RB1 2     p752 3
Interleukin 15 Receptor, Beta1 2     CD1222
High Affinity IL-2 Receptor Subunit Beta2 3     P70-752
IL-2RB2 3     High Affinity IL-2 Receptor Beta Subunit2
CD122 Antigen2 3     Interleukin-2 Receptor Subunit Beta2
IL-2 Receptor Subunit Beta2 3     p70-753

External Ids:    HGNC: 60091   Entrez Gene: 35602   Ensembl: ENSG000001003857   OMIM: 1467105   UniProtKB: P147843   

Export aliases for IL2RB gene to outside databases

Previous GC identifers: GC22M034136 GC22M035764 GC22M035846 GC22M020487

(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for IL2RB Gene:
The interleukin 2 receptor, which is involved in T cell-mediated immune responses, is present in 3 forms with
respect to ability to bind interleukin 2. The low affinity form is a monomer of the alpha subunit and is not
involved in signal transduction. The intermediate affinity form consists of an alpha/beta subunit heterodimer,
while the high affinity form consists of an alpha/beta/gamma subunit heterotrimer. Both the intermediate and high
affinity forms of the receptor are involved in receptor-mediated endocytosis and transduction of mitogenic
signals from interleukin 2. The protein encoded by this gene represents the beta subunit and is a type I membrane
protein. (provided by RefSeq, Jul 2008)

GeneCards Summary for IL2RB Gene: 
IL2RB (interleukin 2 receptor, beta) is a protein-coding gene. Diseases associated with IL2RB include occipital neuralgia, and granulomatous orchitis, and among its related super-pathways are STAT3 Pathway and IL2-mediated signaling events. GO annotations related to this gene include interleukin-2 receptor activity and interleukin-2 binding.

UniProtKB/Swiss-Prot: IL2RB_HUMAN, P14784
Function: Receptor for interleukin-2. This beta subunit is involved in receptor mediated endocytosis and
transduces the mitogenic signals of IL2

Gene Wiki entry for IL2RB Gene

(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 73), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000022.10  NT_011520.12  NC_018933.2  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the IL2RB gene promoter:
         Elk-1   GATA-3   STAT5A   GATA-2   GATA-1   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmidIL2RB promoter sequence
   Search SABiosciences Chromatin IP Primers for IL2RB

QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat IL2RB

Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 22q13.1   Ensembl cytogenetic band:  22q12.3   HGNC cytogenetic band: 22q13

IL2RB Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
IL2RB gene location

GeneLoc information about chromosome 22         GeneLoc Exon Structure

GeneLoc location for GC22M037515:  view genomic region     (about GC identifiers)

37,521,878 bp from pter      End:
37,571,094 bp from pter
49,217 bases      Orientation:
minus strand

(According to UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MAXQB RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Cloud-Clone Corp.,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Cloud-Clone Corp., Ontologies according to Gene Ontology Consortium 01 Oct 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, and/or Cloud-Clone Corp.)
About This Section

UniProtKB/Swiss-Prot: IL2RB_HUMAN, P14784 (See protein sequence)
Recommended Name: Interleukin-2 receptor subunit beta precursor  
Size: 551 amino acids; 61117 Da
Subunit: Non-covalent dimer of an alpha and a beta subunit. IL2R exists in 3 different forms: a high affinity
dimer, an intermediate affinity monomer (beta subunit), and a low affinity monomer (alpha subunit). The high and
intermediate affinity forms also associate with a gamma subunit. Interacts with SHB upon interleukin stimulation.
Interacts with HTLV-1 accessory protein p12I
Subcellular location: Membrane; Single-pass type I membrane protein
6 PDB 3D structures from and Proteopedia for IL2RB:
1ILM (3D)        1ILN (3D)        2B5I (3D)        2ERJ (3D)        3QAZ (3D)        4GS7 (3D)    
Secondary accessions: B2R765

Explore the universe of human proteins at neXtProt for IL2RB: NX_P14784

Explore proteomics data for IL2RB at MOPED 

Post-translational modifications:

  • View modification sites using PhosphoSitePlus
  • View neXtProt modification sites for NX_P14784

  • IL2RB Protein expression data from MOPED1, PaxDb2 and MAXQB3 :    About this image 

    IL2RB Protein Expression
    REFSEQ proteins: NP_000869.1  
    ENSEMBL proteins: 
     ENSP00000216223   ENSP00000403731   ENSP00000402685   ENSP00000400416   ENSP00000401020  
    Reactome Protein details: P14784
    Human Recombinant Protein Products for IL2RB: 
    Browse Purified and Recombinant Proteins at EMD Millipore
    R&D Systems Recombinant & Natural Proteins for IL2RB (IL-2 R beta)
    Browse recombinant and purified proteins available from Enzo Life Sciences
    Browse OriGene full length recombinant human proteins expressed in human HEK293 cells
    OriGene Protein Over-expression Lysate for IL2RB
    OriGene Custom MassSpec 
    OriGene Custom Protein Services for IL2RB
    GenScript Custom Purified and Recombinant Proteins Services for IL2RB
    Novus Biologicals IL2RB Proteins
    Novus Biologicals IL2RB Lysates
    Sino Biological Recombinant Protein for IL2RB
    Sino Biological Cell Lysate for IL2RB 
    Browse ProSpec Recombinant Proteins
    Browse Proteins at Cloud-Clone Corp. 

    Gene Ontology (GO): 3 cellular component terms (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005886plasma membrane TAS--
    GO:0005887integral to plasma membrane TAS8514792
    GO:0009897external side of plasma membrane ISS--

    IL2RB for ontologies           About GeneDecksing

    IL2RB Antibody Products: 
    Browse EMD Millipore's Extensive Line of Mono- and Polyclonal Antibodies
    R&D Systems Antibodies for IL2RB (IL-2 R beta)
    Cell Signaling Technology (CST) Antibodies for IL2RB 
    Browse OriGene Antibodies
    OriGene Custom Antibody Services for IL2RB
    GenScript Custom Superior Antibodies Services for IL2RB
    Novus Biologicals IL2RB Antibodies
    Abcam antibodies for IL2RB
    Browse Antibodies at Cloud-Clone Corp. 
    ThermoFisher Antibodies for IL2RB
    LSBio Antibodies in human, mouse, rat for IL2RB 

    Assay Products for IL2RB: 
    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Assay Services for IL2RB
    R&D Systems Proteome Profiler Antibody Arrays for IL2RB (IL-2 R beta)
    GenScript Custom Assay Services for IL2RB
    Browse Enzo Life Sciences for kits & assays
    Browse ELISAs at Cloud-Clone Corp. 
    Browse CLIAs at Cloud-Clone Corp.

    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section
    HGNC Gene Families: 
    CD: CD molecules
    IL: Interleukins and interleukin receptors

    IUPHAR Guide to PHARMACOLOGY protein family classification: Interleukin-2 receptor β subunit 
    IL-2 receptor family

    3 InterPro protein domains:
     IPR003961 Fibronectin_type3
     IPR013783 Ig-like_fold
     IPR003531 Hempt_rcpt_S_F1_CS

    Graphical View of Domain Structure for InterPro Entry P14784

    ProtoNet protein and cluster: P14784

    1 Blocks protein domain: IPB003531 Short hematopoietin receptor

    UniProtKB/Swiss-Prot: IL2RB_HUMAN, P14784
    Domain: The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular
    transport and cell-surface receptor binding
    Domain: The box 1 motif is required for JAK interaction and/or activation
    Similarity: Belongs to the type I cytokine receptor family. Type 4 subfamily
    Similarity: Contains 1 fibronectin type-III domain

    IL2RB for domains           About GeneDecksing

    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase, shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Sirion Biotech, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, Vector BioLabs, and Sirion Biotech, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene.)
    About This Section

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: IL2RB_HUMAN, P14784
    Function: Receptor for interleukin-2. This beta subunit is involved in receptor mediated endocytosis and
    transduces the mitogenic signals of IL2

         Genatlas biochemistry entry for IL2RB:
    interleukin 2,high affinity receptor,beta chain 70-75kDa,hematopoietic receptor family,expressed in various

         Gene Ontology (GO): 3 molecular function terms (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0004911contributes to interleukin-2 receptor activity TAS2467293
    GO:0005515protein binding ----
    GO:0019976interleukin-2 binding ISS--
    IL2RB for ontologies           About GeneDecksing

         1 GenomeRNAi human phenotype for IL2RB:
     Synthetic lethal with Ras 

         11 MGI mutant phenotypes (inferred from 1 allele(MGI details for Il2rb):
     behavior/neurological  cellular  embryogenesis  endocrine/exocrine gland  growth/size 
     hematopoietic system  immune system  integument  liver/biliary system  mortality/aging 
     reproductive system 

    IL2RB for phenotypes           About GeneDecksing

    Animal Models:
         MGI mouse knock-out Il2rbtm1Mak for IL2RB

       inGenious Targeting Laboratory - Custom generated mouse model solutions for IL2RB 
       inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for IL2RB

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for IL2RB 
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for IL2RB 

    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat IL2RB
    8/11 QIAGEN miScript miRNA Assays for microRNAs that regulate IL2RB (see all 11):
    hsa-miR-146b-3p hsa-miR-15a hsa-miR-497 hsa-miR-424 hsa-miR-24 hsa-miR-195 hsa-miR-16 hsa-miR-15b
    SwitchGear 3'UTR luciferase reporter plasmidIL2RB 3' UTR sequence
    Inhib. RNA
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for IL2RB
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat IL2RB

    Gene Editing
    DNA2.0 Custom Protein Engineering Service for IL2RB
    Sirion Biotech Customized adenovirus for overexpression of IL2RB

    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene clones in human, mouse for IL2RB (see all 6)
    OriGene ORF clones in mouse, rat for IL2RB
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IL2RB (NM_000878)
    Sino Biological Human cDNA Clone for IL2RB
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IL2RB
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IL2RB
    Sirion Biotech Customized lentivirus for stable overexpression of IL2RB 
                         Customized lentivirus expression plasmids for stable overexpression of IL2RB 

    Cell Line
    GenScript Custom overexpressing Cell Line Services for IL2RB
    Search LifeMap BioReagents cell lines for IL2RB
    In Situ Assay

    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IL2RB

    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene).
    About This Section

    SuperPaths for IL2RB About   (see all 28)                                                                                              See pathways by source

    SuperPathContained pathways About
    1PEDF Induced Signaling
    NFAT Signaling and Lymphocyte Interactions0.57
    Glucocorticoid Receptor Signaling0.43
    PGC1Alpha Pathway0.51
    Cytokine-cytokine receptor interaction0.43
    STAT3 Pathway0.47
    2IL-2 Signaling pathway
    IL2-mediated signaling events0.49
    IL-2 Signaling pathway0.49
    3TGF-Beta Pathway
    TGF-Beta Pathway0.60
    JAK-STAT Pathway0.57
    MAPK Family Pathway0.60
    JNK Pathway0.51
    4Interleukin-3, 5 and GM-CSF signaling
    Interleukin receptor SHC signaling0.67
    Interleukin-3, 5 and GM-CSF signaling0.57
    Interleukin-2 signaling0.67
    Signaling by Interleukins0.45
    5Akt Signaling
    Akt Signaling0.60
    Tec Kinases Signaling0.55
    p38 Signaling0.60

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways

    2 EMD Millipore Pathways for IL2RB
        Immune response IL-22 signaling pathway
    Immune response IL-2 activation and signaling pathway

    4 R&D Systems Pathways for IL2RB
        IL-2 Signaling Pathways
    IL-15 Signaling Pathways
    IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types
    IL-2 Signaling and its Primary Biological Effects in Different Immune Cell Types

    5/15 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for IL2RB (see all 15)
        STAT3 Pathway
    Molecular Mechanisms of Cancer
    Antioxidant Action of Vitamin-C
    Glucocorticoid Receptor Signaling
    ICos-ICosL Pathway in T-Helper Cell

    2 Cell Signaling Technology (CST) Pathways for IL2RB
        Lymphocyte Signaling
    Tyrosine Kinases / Adaptors

    2 GeneGo (Thomson Reuters) Pathways for IL2RB
        Immune response IL-22 signaling pathway
    Immune response IL-2 activation and signaling pathway

    5/8 BioSystems Pathways for IL2RB (see all 8)
        IL-5 Signaling Pathway
    IL-2 Signaling pathway
    Downstream signaling in naive CD8+ T cells
    IL12-mediated signaling events
    IL2 signaling events mediated by PI3K

    5/6        Reactome Pathways for IL2RB (see all 6)
        Interleukin receptor SHC signaling
    Interleukin-2 signaling
    Cytokine Signaling in Immune system
    Interleukin-3, 5 and GM-CSF signaling
    Signaling by Interleukins

    5/7         Kegg Pathways  (Kegg details for IL2RB) (see all 7):
        Cytokine-cytokine receptor interaction
    PI3K-Akt signaling pathway
    Jak-STAT signaling pathway

    IL2RB for pathways           About GeneDecksing


        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for IL2RB

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    5/91 Interacting proteins for IL2RB (P147842, 3 ENSP000002162234) via UniProtKB, MINT, STRING, and/or I2D (see all 91)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    STAT5AP422292, 3, ENSP000003412084MINT-8035160 I2D: score=4 STRING: ENSP00000341208
    STAT5BP516922, 3, ENSP000002933284MINT-8035171 I2D: score=4 STRING: ENSP00000293328
    SHBQ154642, 3, ENSP000003669364MINT-8035186 I2D: score=3 STRING: ENSP00000366936
    GNB2L1P632443, ENSP000003660134I2D: score=4 STRING: ENSP00000366013
    SHC1P293533, ENSP000004013034I2D: score=4 STRING: ENSP00000401303
    About this table

    Gene Ontology (GO): 5/6 biological process terms (GO ID links to tree view) (see all 6):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0006461protein complex assembly TAS2467293
    GO:0007165signal transduction TAS2785715
    GO:0019048modulation by virus of host morphology or physiology IEA--
    GO:0019221cytokine-mediated signaling pathway IDA7736574
    GO:0038110interleukin-2-mediated signaling pathway TAS2467293

    IL2RB for ontologies           About GeneDecksing

    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    IL2RB for compounds           About GeneDecksing

    Browse Small Molecules at EMD Millipore
    Browse drugs & compounds from Enzo Life Sciences

    Browse Tocris compounds for IL2RB

    4 DrugBank Compounds for IL2RB    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    AldesleukinIL-2 (see all 4)85898-30-2targetagonist modulator16542139 16617454 16569767 11752352 16477002 16596189
    Basiliximabchimeric mouse-human antiCD25 (see all 2)152923-56-3targetantibody11840795 11752352 12826150 10188761 12667677 10708100
    DaclizumabAnti-IL-2 (see all 3)152923-56-3targetantibody15022409 2571203 11752352 2647626 12372041 15814281
    Denileukin diftitoxDiphtheria toxin precursor (see all 3)173146-27-5targetagonist16516670 15811959 11752352 17187516 18684057

    10/118 Novoseek inferred chemical compound relationships for IL2RB gene (see all 118)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    daclizumab 75.5 25 11359452 (2), 20415630 (2), 9794841 (1), 11004222 (1) (see all 21)
    neopterin 74.5 56 9892527 (5), 7647844 (3), 17975200 (2), 1606739 (2) (see all 41)
    okt3 66.8 13 2148645 (2), 2121373 (2), 1916932 (1), 8027539 (1) (see all 9)
    denileukin diftitox 65.3 12 15353540 (1), 19707452 (1), 16410787 (1), 18295790 (1) (see all 6)
    basiliximab 62.4 14 12667677 (2), 11840795 (2), 10188761 (1), 17150025 (1) (see all 10)
    cyclosporin a 58.7 30 1864010 (2), 1864013 (1), 1346344 (1), 7509146 (1) (see all 26)
    r-il-2 53.8 1 7576120 (1)
    thymoglobulin 53.4 7 15041353 (1), 15575919 (1), 17927304 (1), 19236436 (1) (see all 7)
    ionomycin 50.8 5 8344700 (1), 1654606 (1), 2017664 (1), 11347470 (1) (see all 5)
    tyrosine 50.4 68 1639773 (3), 8089104 (3), 2007186 (3), 7612266 (2) (see all 50)

    Search CenterWatch for drugs/clinical trials and news about IL2RB

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    Conferences by KenesGroup, exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Sirion Biotech, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for IL2RB gene: 

    Unigene Cluster for IL2RB:

    Interleukin 2 receptor, beta
    Hs.474787  [show with all ESTs]
    Unigene Representative Sequence: NM_000878
    7 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000216223(uc003aqv.1) ENST00000483573 ENST00000453962 ENST00000429622
    ENST00000461607 ENST00000440958 ENST00000445595
    Congresses - knowledge worth sharing:  
    European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 10 - 13 May 2014

    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat IL2RB
    8/11 QIAGEN miScript miRNA Assays for microRNAs that regulate IL2RB (see all 11):
    hsa-miR-146b-3p hsa-miR-15a hsa-miR-497 hsa-miR-424 hsa-miR-24 hsa-miR-195 hsa-miR-16 hsa-miR-15b
    SwitchGear 3'UTR luciferase reporter plasmidIL2RB 3' UTR sequence
    Inhib. RNA
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for IL2RB
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat IL2RB
    OriGene clones in human, mouse for IL2RB (see all 6)
    OriGene ORF clones in mouse, rat for IL2RB
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IL2RB (NM_000878)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IL2RB
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IL2RB
    Sirion Biotech Customized lentivirus for stable overexpression of IL2RB 
                         Customized lentivirus expression plasmids for stable overexpression of IL2RB 
    OriGene qPCR primer pairs and template standards for IL2RB
    OriGene qSTAR qPCR primer pairs in human, mouse for IL2RB
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat IL2RB
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat IL2RB
      QIAGEN QuantiFast Probe-based Assays in human, mouse, rat IL2RB

    Additional mRNA sequence: 

    AK312860.1 BC025691.1 CR456506.1 M26062.1 

    7 DOTS entries:

    DT.312677  DT.120651820  DT.120651728  DT.120651741  DT.91695341  DT.65286096  DT.91692959 

    24/209 AceView cDNA sequences (see all 209):

    BM722009 AI989994 BQ712725 M26062 CR608415 CR607090 CR606760 CD633231 
    NM_182486 BQ053622 AY358374 AK128125 AI968918 H55712 BM549427 BU542015 
    CR456506 H55722 H55367 NM_000878 BU859813 BC025691 CB217036 BX336597 

    GeneLoc Exon Structure

    4 Alternative Splicing Database (ASD) splice patterns (SP) for IL2RB    About this scheme

    ExUns: 1 ^ 2 ^ 3a · 3b ^ 4a · 4b ^ 5a · 5b · 5c ^ 6a · 6b ^ 7 ^ 8a · 8b ^ 9 ^ 10
    SP1:                          -                       -                                             
    SP2:                          -           -     -     -     -                                       
    SP3:                          -                                                                     

    ECgene alternative splicing isoforms for IL2RB

    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    IL2RB expression in normal human tissues (normalized intensities)      IL2RB embryonic expression: see
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    IL2RB Expression
    About this image

    IL2RB expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database 
     5/4 selected tissues (see all 4) fully expand
     Thymus (Hematopoietic System)    fully expand to see all 3 entries
             T Helper Cells Thymus
     Blood (Hematopoietic System)    fully expand to see all 3 entries
             Natural Killer Cells Peripheral Blood
     Lung (Respiratory System)
     Spleen (Hematopoietic System)

    See IL2RB Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for IL2RB

    SOURCE GeneReport for Unigene cluster: Hs.474787
        SABiosciences Expression via Pathway-Focused PCR Arrays including IL2RB: 
              Interferons & Receptors in human mouse rat
              Inflammatory Cytokines & Receptors in human mouse rat
              T-Cell Anergy & Immune Tolerance in human mouse rat
              Inflammatory Response & Autoimmunity 384HT in human mouse rat

    OriGene qPCR primer pairs and template standards for IL2RB
    OriGene qSTAR qPCR primer pairs in human, mouse for IL2RB
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat IL2RB
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat IL2RB
    QIAGEN QuantiFast Probe-based Assays in human, mouse, rat IL2RB
    In Situ
    Assay Products:

    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IL2RB

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of chordates.

    Orthologs for IL2RB gene from 4/9 species (see all 9)    About this table
    Organism Taxonomic
    Gene Description Human
    (Mus musculus)
    Mammalia Il2rb1 , 5 interleukin 2 receptor, beta chain1, 5 71.04(n)1
      15 (37.52 cM)5
    161851  NM_008368.41  NP_032394.11 
    (Gallus gallus)
    Aves IL2RB6
    Uncharacterized protein
    1 ↔ 1
    (Anolis carolinensis)
    Reptilia IL2RB6
    interleukin 2 receptor, beta
    1 ↔ 1
    (Danio rerio)
    Actinopterygii il2rb1 interleukin 2 receptor, beta 43.52(n)
      793920  NM_001128267.1  NP_001121739.1 

    ENSEMBL Gene Tree for IL2RB (if available)
    TreeFam Gene Tree for IL2RB (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to Build 68)
    About This Section
    Paralogs for IL2RB gene

    IL2RB for paralogs           About GeneDecksing

    1 Pseudogene for IL2RB

    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    10/720 SNPs in IL2RB are shown (see all 720)    About this table     
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    Chr 22 posSequence#AA
    C,F,H--37521478(-) CCAGAC/TCAGGG 1 -- ds50016Minor allele frequency- T:0.01NS EA 504
    --37521544(+) GGGGG-/ATAGAG 1 -- ds50010--------
    C--37521546(+) TAGAG-/A/GAG 
    3 -- ds5001 cds10--------
    --37521548(+) GATAG-/AGGGGG 1 -- ds50010--------
    C--37521646(+) TATTT-/CCCCAG 1 -- ds50010--------
    C,F--37521662(-) TCCCAC/TAAGTC 1 -- ds50012Minor allele frequency- T:0.01NS 82
    --37521670(+) GGATAA/TGGCCA 1 -- ds50010--------
    --37521802(+) GTCTTC/TGACAG 1 -- ds50010--------
    --37521838(+) TTTAAG/TAGACA 1 -- ds50010--------
    C--37521859(+) CGCAGA/GCAATG 1 -- ds50010--------

    HapMap Linkage Disequilibrium report for IL2RB (37521878 - 37571094 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 6 variations for IL2RB:    About this table     
    Variant IDTypeSubtypePubMed ID
    esv34015CNV Loss18971310
    nsv829203CNV Loss20364138
    nsv915016CNV Loss21882294
    nsv834187CNV Loss17160897
    nsv915017CNV Gain21882294
    nsv459882CNV Gain19166990

    Human Gene Mutation Database (HGMD): IL2RB
    SABiosciences Cancer Mutation PCR Assays
    SeqTarget long-range PCR primers for resequencing IL2RB
    DNA2.0 Custom Variant and Variant Library Synthesis for IL2RB

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Conferences by KenesGroup, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section
    OMIM gene information: 146710    OMIM disorders: --

    20/170 diseases for IL2RB (see all 170):    About MalaCards
    occipital neuralgia    granulomatous orchitis    central pontine myelinolysis    berylliosis
    chronic progressive multiple sclerosis    herpes simplex encephalitis    intravascular large b-cell lymphoma    primary malignant lymphoma
    extramedullary plasmacytoma    orchitis    hematologic cancer    t-lymphocytopenia
    posterior uveitis    polymyalgia rheumatica    panniculitis    dermatitis herpetiformis
    mycosis fungoides    acute graft versus host disease    bronchogenic carcinoma    epidermolysis bullosa acquisita

    IL2RB for disorders           About GeneDecksing

    Congresses - knowledge worth sharing:  
    The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) 9 - 13 March 2014
    Alzheimer's & Parkinson's Diseases Congress (ADPD) 18 - 22 March 2015

    10/94 Novoseek inferred disease relationships for IL2RB gene (see all 94)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    severe combined immunodeficiency, x-linked 72.6 11 16138102 (1), 7718508 (1), 7523745 (1), 7632950 (1) (see all 9)
    necrosis 63.9 160 11505128 (2), 1910217 (2), 9060545 (2), 8146526 (2) (see all 99)
    tumors 50 172 16996570 (3), 8146526 (3), 10685665 (3), 11505128 (2) (see all 99)
    autoimmune diseases 48.2 17 1934612 (1), 8580481 (1), 15528977 (1), 2081786 (1) (see all 17)
    leukemia hairy cell 47.8 5 2072745 (1), 8107487 (1), 8329708 (1), 1700727 (1) (see all 5)
    leukemia t-cell 45.9 6 8102412 (1), 1379847 (1), 2298500 (1), 8648694 (1) (see all 5)
    diphtheria 45.7 7 15353540 (1), 16586495 (1), 9796831 (1), 16410787 (1) (see all 7)
    metastatic melanoma 41.9 1 10711641 (1)
    htlv-i infections 41.8 1 1982452 (1)
    rheumatoid arthritis 41.4 15 2289327 (2), 7738942 (2), 8039284 (2), 7921769 (1) (see all 12)

    Genetic Association Database (GAD): IL2RB
    Human Genome Epidemiology (HuGE) Navigator: IL2RB (39 documents)

    Export disorders for IL2RB gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for IL2RB gene, integrated from 9 sources (see all 1217) (see top 10):
    (articles sorted by number of sources associating them with IL2RB)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. (PubMed id 16477002)1, 2, 7 Stauber D.J.... Wilson I.A. (2006)
    2. IL-2 receptor signaling through the Shb adapter protein in T and NK cells. (PubMed id 12200137)1, 2, 9 Lindholm C.K. (2002)
    3. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. (PubMed id 17108990)1, 4, 9 Bucheton B....Dessein A.J. (2007)
    4. IL-2 gene C/T polymorphism is associated with prostate cancer. (PubMed id 17115417)1, 4, 9 Wu H.C....Chen W.C. (2006)
    5. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. (PubMed id 8648694)1, 2, 9 Mulloy J.C.... Franchini G. (1996)
    6. Pathway-driven gene stability selection of two rheuma toid arthritis GWAS identifies and validates new susceptibility genes in recept or mediated signalling pathways. (PubMed id 21653640)1, 4 Eleftherohorinou H....Coin L.J. (2011)
    7. Genome-wide association analysis of autoantibody posit ivity in type 1 diabetes cases. (PubMed id 21829393)1, 4 Plagnol V....Todd J.A. (2011)
    8. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. (PubMed id 20379614)1, 4 Rose J.E....Uhl G.R. (2010)
    9. Genetic variants in inflammation-related genes are as sociated with radiation-induced toxicity following treatment for non-small cell lung cancer. (PubMed id 20811626)1, 4 Hildebrandt M.A....Wu X. (2010)
    10. Investigation of potential non-HLA rheumatoid arthrit is susceptibility loci in a European cohort increases the evidence for nine mar kers. (PubMed id 20498205)1, 4 Plant D....Worthington J. (2010)
    11. A novel galectin-1 and interleukin 2 receptor I^ haplo type is associated with autoimmune myasthenia gravis. (PubMed id 20728947)1, 4 PA!l Z....BuzA!s E.I. (2010)
    12. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. (PubMed id 20049410)1, 4 Wieczorek S....Epplen J.T. (2010)
    13. Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth. (PubMed id 20140262)1, 4 Ryckman K.K....Jacobsson B. (2010)
    14. Polymorphisms in the IL2, IL2RA and IL2RB genes in mu ltiple sclerosis risk. (PubMed id 20179739)1, 4 Cavanillas M.L....Urcelay E. (2010)
    15. Variation at the NFATC2 locus increases the risk of t hiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipr il and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)1, 4 Bailey S.D....Anand S. (2010)
    16. A large-scale, consortium-based genomewide associatio n study of asthma. (PubMed id 20860503)1, 4 Moffatt M.F....Cookson W.O. (2010)
    17. Interleukin-9 polymorphism in infants with respirator y syncytial virus infection: an opposite effect in boys and girls. (PubMed id 20503287)1, 4 Schuurhof A....Janssen R. (2010)
    18. L-type voltage-dependent calcium channel alpha subuni t 1C is a novel candidate gene associated with secondary hyperparathyroidism: a n application of haplotype-based analysis for multiple linked single nucleotide polymorphisms. (PubMed id 20424473)1, 4 Yokoyama K....Hosoya T. (2010)
    19. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. (PubMed id 19258923)1, 4 Siezen C.L....Janssen R. (2009)
    20. Interleukin-2 receptor beta gene C627T polymorphism i n Korean women with endometriosis: a case-control study. (PubMed id 19602517)1, 4 Lee G.H....Moon S.Y. (2009)
    21. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients . (PubMed id 19817957)1, 4 Segat L....Crovella S. (2009)
    22. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. (PubMed id 19471255)1, 4 MA!rquez A....Urcelay E. (2009)
    23. Racial disparity in pathophysiologic pathways of pret erm birth based on genetic variants. (PubMed id 19527514)1, 4 Menon R....Thorsen P. (2009)
    24. Coeliac disease associated risk variants in TNFAIP3 and REL implicate altered NF-{kappa}B signalling. (PubMed id 19240061)1, 4 Trynka G....Wijmenga C. (2009)
    25. Role of inflammation gene polymorphisms on pain sever ity in lung cancer patients. (PubMed id 19773451)1, 4 Reyes-Gibby C.C....Shete S. (2009)
    26. Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. (PubMed id 18818748)1, 4 Velez D.R....Menon R. (2008)
    27. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. (PubMed id 18715339)1, 4 Dhiman N....Poland G.A. (2008)
    28. Genetic variation in immune signaling genes differentially expressed in asthmatic lung tissues. (PubMed id 18774388)1, 4 Tremblay K....Laprise C. (2008)
    29. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. (PubMed id 19019335)1, 4 Velez D.R....Menon R. (2008)
    30. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. (PubMed id 17152005)1, 4 Dhiman N....Jacobson R.M. (2007)
    31. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. (PubMed id 17703412)1, 4 Janssen R....Hoebee B. (2007)
    32. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. (PubMed id 16293754)1, 2 Wang X.... Garcia K.C. (2005)
    33. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. (PubMed id 16380905)1, 4 Fallin M.D....Pulver A.E. (2005)
    34. A genome annotation-driven approach to cloning the human ORFeome. (PubMed id 15461802)1, 2 Collins J.E.... Dunham I. (2004)
    35. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)1, 2 Gerhard D.S....Malek J. (2004)
    36. Genetic variations in humans associated with differences in the course of hepatitis C. (PubMed id 15063762)1, 4 Saito T....Kawata S. (2004)
    37. Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. (PubMed id 15191519)1, 4 Moreno M....Arcos-Burgos M. (2004)
    38. The DNA sequence of human chromosome 22. (PubMed id 10591208)1, 2 Dunham I....O'Brien K.P. (1999)
    39. The interleukin-2 and interleukin-4 receptors studied by molecular modelling. (PubMed id 7529123)1, 2 Bamborough P.... Richards W.G. (1994)
    40. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. (PubMed id 2785715)1, 2 Hatakeyama M.... Taniguchi T. (1989)
    41. Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production. (PubMed id 11238664)1, 9 Corrigall V.M....Panayi G.S. (2001)
    42. Interleukin-2 (IL-2) induces tyrosine kinase-dependent translocation of active raf-1 from the IL-2 receptor into the cytosol. (PubMed id 1639773)1, 9 Maslinski W....Strom T.B. (1992)
    43. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. (PubMed id 10602027)1, 9 Delespine-Carmagnat M....Bertoglio J. (2000)
    44. Basiliximab interferes with the detection of soluble IL-2 receptor by the Immulite Immunoassay system. (PubMed id 12667677)7, 9 WarlAc M.C....Metselaar H.J. (2003)
    45. [Immune suppression by combination therapy with basil iximab and cyclosporin in high risk keratoplasty. A pilot study] (PubMed id 11840795)7, 9 Schmitz K....Behrens-Baumann W. (2002)
    46. Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation. (PubMed id 9774657)1, 9 Migone T.S....Leonard W.J. (1998)
    47. Optimizing denileukin diftitox (Ontak) therapy. (PubMed id 18684057)7, 9 Duvic M. and Talpur R. (2008)
    48. Clinical experience with denileukin diftitox (ONTAK). (PubMed id 16516670)7, 9 Foss F. (2006)
    49. Airway inflammation in asymptomatic children with episodic wheeze. (PubMed id 16617454)7, 9 Maclennan C....Freezer N.J. (2006)
    50. Differential regulation of T-cell growth by IL-2 and IL-15. (PubMed id 16569767)7, 9 Cornish G.H....Cantrell D.A. (2006)
    51. [New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies] (PubMed id 15022409)7, 9 AguillA^n J.C....Cuchacovich M. (2003)
    52. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. (PubMed id 10373548)1, 9 Cohney S.J....Johnston J.A. (1999)
    53. Basiliximab. (PubMed id 10188761)7, 9 Onrust S.V. and Wiseman L.R. (1999)
    54. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta. (PubMed id 9553136)1, 9 Zhu M.H....Leonard W.J. (1998)
    55. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. (PubMed id 9520455)1, 9 Migone T.S....Johnston J.A. (1998)
    56. Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. (PubMed id 9176231)1, 9 Stevens A.C....Maslinski W. (1997)
    57. Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120. (PubMed id 9341758)1, 9 Bani L....Theze J. (1997)
    58. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. (PubMed id 8700888)1, 9 Friedmann M.C....Leonard W.J. (1996)
    59. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. (PubMed id 7600304)1, 9 Minami Y....Taniguchi T. (1995)
    60. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. (PubMed id 7973659)1, 9 Miyazaki T....Ihle J.N. (1994)
    61. Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains. (PubMed id 8041779)1, 9 Tanaka N....Sugamura K. (1994)
    62. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. (PubMed id 8294403)1, 9 Ravichandran K.S. and Burakoff S.J. (1994)
    63. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. (PubMed id 8026467)1, 9 Giri J.G....Anderson D. (1994)
    64. Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor beta-subunit. (PubMed id 7693677)1, 9 Kirken R.A....Farrar W.L. (1993)
    65. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated. (PubMed id 2303462)1, 9 Mills G.B....Greene W.C. (1990)
    66. Postthymic expansion in human CD4 naive T cells define d by expression of functional high-affinity IL-2 receptors. (PubMed id 23418630)1 Pekalski M.L....Wicker L.S. (2013)
    67. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. (PubMed id 23341462)1 Rodriguez G....Kirken R.A. (2013)
    68. Evaluation of the IL2/IL21, IL2RA and IL2RB genetic va riants influence on the endogenous non-anterior uveitis genetic predisposition. (PubMed id 23676143)1 Cenit M.C....Martin J. (2013)
    69. Chimeric gc cytokine receptors confer cytokine indepen dent engraftment of human T lymphocytes. (PubMed id 23628622)1 Hunter M.R....Jensen M.C. (2013)
    70. Lack of association of IL-2RA and IL-2RB polymorphisms with rheumatoid arthritis in a Han Chinese population. (PubMed id 23512675)1 Zhu J....Zhou B. (2013)
    71. Multistage analysis of variants in the inflammation pa thway and lung cancer risk in smokers. (PubMed id 22573796)1 Spitz M.R....Amos C.I. (2012)
    72. Soluble cytokine receptors (sIL-2Ra, sIL-2Rb) induce s ubunit-specific behavioral responses and accumulate in the cerebral cortex and b asal forebrain. (PubMed id 22558434)1 Zalcman S.S....Siegel A. (2012)
    73. Impact of IL2 and IL2RB genetic polymorphisms in kidn ey transplantation. (PubMed id 21839273)1 Park S.J....Kim Y.H. (2011)
    74. The basis of distinctive IL-2- and IL-15-dependent si gnaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survi val but not T effector-memory cell development. (PubMed id 21984699)1 Castro I....Malek T.R. (2011)
    75. Placenta-specific expression of the interleukin-2 (IL -2) receptor I^ subunit from an endogenous retroviral promoter. (PubMed id 21865161)1 Cohen C.J....Mager D.L. (2011)
    76. Genetic variation at 5 new autosomal short tandem rep eat markers (D10S1248, D22S1045, D2S441, D1S1656, D12S391) in a population-base d sample from Maghreb region. (PubMed id 21674833)1 Cortellini V....Verzeletti A. (2011)
    77. Peripherally induced human regulatory T cells uncoupl e Kv1.3 activation from TCR-associated signaling. (PubMed id 21834013)1 Reneer M.C....Marti F. (2011)
    78. Hrs recognizes a hydrophobic amino acid cluster in cy tokine receptors during ubiquitin-independent endosomal sorting. (PubMed id 21362618)1 Amano Y....Takeshita T. (2011)
    79. Association of SRC-related kinase Lyn with the interl eukin-2 receptor and its role in maintaining constitutive phosphorylation of JA K/STAT in human T-cell leukemia virus type 1-transformed T cells. (PubMed id 21345943)1 Shuh M....Derse D. (2011)
    80. The role of rheumatoid arthritis genetic susceptibili ty markers in the prediction of erosive disease in patients with early inflamma tory polyarthritis: results from the Norfolk Arthritis Register. (PubMed id 20219786)1 Plant D....Barton A. (2010)
    81. Ectodomain shedding of interleukin-2 receptor beta an d generation of an intracellular functional fragment. (PubMed id 20495002)1 de Oca P.M....Gesbert F. (2010)
    82. ZNF300, a recently identified human transcription fac tor, activates the human IL-2RI^ promoter through the overlapping ZNF300/EGR1 bi nding site. (PubMed id 20585888)1 Xue L....Li W. (2010)
    83. Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation. (PubMed id 21085059)4 Israni A....Oetting W.S. (2010)
    84. New genetic associations detected in a host response study to hepatitis B vaccine. (PubMed id 20237496)1 Davila S....Seielstad M. (2010)
    85. Protein phosphatase 2A regulates interleukin-2 recept or complex formation and JAK3/STAT5 activation. (PubMed id 19923221)1 Ross J.A....Kirken R.A. (2010)
    86. Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheuma toid arthritis in African Americans. (PubMed id 21120996)4 Hughes L.B....Bridges S.L. (2010)
    87. Gene-centric association signals for lipids and apoli poproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)1 Talmud P.J.... . (2009)
    88. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. (PubMed id 18791162)1 Fukumoto R....Franchini G. (2009)
    89. Association of IL2RA and IL2RB with rheumatoid arthri tis: a replication study in a Dutch population. (PubMed id 19822714)1 Kurreeman F.A....Toes R.E. (2009)
    90. NEDD4-2 associates with gamma(c) and regulates its de gradation rate. (PubMed id 19615332)1 MalardAc V....Gesbert F. (2009)
    91. Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U). (PubMed id 18592269)1 Kitagawa J....Moriwaki H. (2009)
    92. Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients. (PubMed id 18490721)1 Zheng C.F....Mody C.H. (2008)
    93. Human IL-Rbeta chains form IL-2 binding homodimers. (PubMed id 18299274)1 Pillet A.H....Rose T. (2008)
    94. Ubiquitin-independent binding of Hrs mediates endosomal sorting of the interleukin-2 receptor beta-chain. (PubMed id 18445679)1 Yamashita Y....Takeshita T. (2008)
    95. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera. (PubMed id 18589435)1 Sogo T....Nagamune T. (2008)
    96. Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain. (PubMed id 18829468)1 Malka Y....Henis Y.I. (2008)
    97. Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders. (PubMed id 17187516)7 Turturro F. (2007)
    98. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. (PubMed id 17554300)4  . (2007)
    99. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. (PubMed id 17052657)4 Fung H.C....Singleton A. (2006)
    100. Construction and characterization of a novel fusion p rotein consisting of anti-CD3 antibody fused to recombinant interleukin-2. (PubMed id 16596189)7 Lee K.D....Cheng M.L. (2006)
    101. Reduced secondary cytokine induction by BAY 50-4798, a high-affinity receptor-specific interleukin-2 analog. (PubMed id 16542139)7 Steppan S....Cassell D.J. (2006)
    102. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins. (PubMed id 16284400)1 Mortier E....Jacques Y. (2006)
    103. Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis. (PubMed id 16084898)1 Hsieh Y.Y....Tsai C.H. (2005)
    104. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma. (PubMed id 15811959)7 Foss F....DiVenuti G. (2005)
    105. Daclizumab therapy in kidney transplantation-differen t mechanisms of action in- versus ex-vivo? (PubMed id 15814281)7 Forrest K....Goebel J. (2005)
    106. Complete sequencing and characterization of 21,243 full-length human cDNAs. (PubMed id 14702039)2 Ota T.... Sugano S. (2004)
    107. Synthetic peptides mapping to epitopes of the extracellular domain of the interleukin-2 receptor beta-chain to inhibit T-cell activation. (PubMed id 15350462)1 Parissi T....Mouzaki A. (2004)
    108. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. (PubMed id 14680494)1 Garcia-Tunon I....Royuela M. (2004)
    109. The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex. (PubMed id 12960323)1 Usacheva A....Colamonici O.R. (2003)
    110. Calcineurin-free protocols with basiliximab induction allow patients included in 'old to old' programs achieve standard ki dney transplant function. (PubMed id 12826150)7 Emparan C....Senninger N. (2003)
    111. Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor. (PubMed id 12676936)1 Rose T....Theze J. (2003)
    112. Alternate signalling pathways from the interleukin-2 receptor. (PubMed id 11750878)1 Ellery J.M. and Nicholls P.J. (2002)
    113. Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. (PubMed id 12133952)1 Usacheva A....Colamonici O.R. (2002)
    114. TTD: Therapeutic Target Database. (PubMed id 11752352)7 Chen X....Chen Y.Z. (2002)
    115. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)1 Strausberg R.L....Marra M.A. (2002)
    116. Expression of IL-2alpha and IL-2beta receptors on the membrane surface of human sperm. (PubMed id 12230826)1 Fierro R....Faure G. (2002)
    117. Oligomerization of IL-2Ralpha. (PubMed id 11886175)1 Eicher D.M....Waldmann T.A. (2002)
    118. Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation. (PubMed id 12372041)7 Light J.A....Fowlkes D.L. (2002)
    119. GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines. (PubMed id 11856346)1 Matko J....Damjanovich S. (2002)
    120. Involvement of the ubiquitin/proteasome system in sor ting of the interleukin 2 receptor beta chain to late endocytic compartments. (PubMed id 11359922)1 Rocca A....Dautry-Varsat A. (2001)
    121. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. (PubMed id 11133764)1 Sporri B....Leonard W.J. (2001)
    122. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. (PubMed id 11463390)1 Lamaze C....Dautry-Varsat A. (2001)
    123. IL-2R beta agonist P1-30 acts in synergy with IL-2, IL-4, IL-9, and IL-15: biological and molecular effects. (PubMed id 11035066)1 Eckenberg R....Theze J. (2000)
    124. Prevention of acute allograft rejection in nonhuman p rimate lung transplant recipients: induction with chimeric anti-interleukin-2 r eceptor monoclonal antibody improves the tolerability and potentiates the immun osuppressive activity of a regimen using low doses of both microemulsion cyclos porine and 40-O-(2-hydroxyethyl)-rapamycin. (PubMed id 10708100)7 Hausen B....Morris R.E. (2000)
    125. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. (PubMed id 10825200)1 Zhou Y.J....O'Shea J.J. (2000)
    126. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling. (PubMed id 10514520)1 Aman M.J....Leonard W.J. (1999)
    127. Biochemical analysis of interleukin-2 receptor beta chain phosphorylation by p56(lck). (PubMed id 10214954)1 Delespine-Carmagnat M....Bertoglio J. (1999)
    128. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness. (PubMed id 9637477)1 Selliah N. and Finkel T.H. (1998)
    129. Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid (H9) cell line. (PubMed id 7734194)1 Puri R.K....Aggarwal B.B. (1995)
    130. Association study of schizophrenia and the IL-2 receptor beta chain gene. (PubMed id 8546160)4 Nimgaonkar V.L....Ganguli R. (1995)
    131. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. (PubMed id 7641685)1 Giri J.G....Anderson D.M. (1995)
    132. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. (PubMed id 7736574)1 Miyazaki T....Taniguchi T. (1995)
    133. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. (PubMed id 7973658)1 Russell S.M....Silvennoinen O. (1994)
    134. Soluble IL-2 receptor beta and gamma subunits: ligand binding and cooperativity. (PubMed id 8049354)1 Johnson K....Creasey A. (1994)
    135. Characterization of the human interleukin-2 receptor gamma chain gene. (PubMed id 8514792)1 Noguchi M.... Leonard W.J. (1993)
    136. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction. (PubMed id 8483935)1 Kobayashi N....Taniguchi T. (1993)
    137. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. (PubMed id 8493579)1 Chardin P....Bar-Sagi D. (1993)
    138. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. (PubMed id 1394441)1 Purvis S.F....Lederman M.M. (1992)
    139. Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line. (PubMed id 1557373)1 Torigoe T....Reed J.C. (1992)
    140. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. (PubMed id 2047859)1 Hatakeyama M....Taniguchi T. (1991)
    141. The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. (PubMed id 1915291)1 Miyazaki T....Taniguchi T. (1991)
    142. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. (PubMed id 2315327)1 Oyaizu N....Pahwa S. (1990)
    143. Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences. (PubMed id 2333293)1 Gnarra J.R....Leonard W.J. (1990)
    144. The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment. (PubMed id 1973832)1 Shibuya H....Taniguchi T. (1990)
    145. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. (PubMed id 2467293)1 Tsudo M....Miyasaka M. (1989)
    146. Differential IL-2 receptor expression in renal allogr aft recipients treated with an anti-IL-2-receptor antibody. (PubMed id 2571203)7 Ramos E.L....Carpenter C.B. (1989)
    147. Anti-IL-2 receptor monoclonal antibody AMT-13 increas es soluble IL-2 receptor levels in vivo. (PubMed id 2647626)7 Burkhardt K....Loughnan M.S. (1989)
    148. Lymphocyte activation by HIV-1 envelope glycoprotein. (PubMed id 2843775)1 Kornfeld H....Center D.M. (1988)
    149. Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. (PubMed id 3925551)1 Leonard W.J....Greene W.C. (1985)
    150. The role of Kalirin9 in p75/nogo receptor-mediated RhoA activation in cerebellar granule neurons. (PubMed id 18625710)9 Harrington A.W....Yoon S.O. (2008)
    151. Phenotypic analysis of hairy cell leukemia: 'variant' cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25). (PubMed id 8329708)9 de Totero D....Foa R. (1993)
    152. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. (PubMed id 1848580)9 Krause D.S. and Deutsch C. (1991)
    153. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and their soluble receptors in coal workers' pneumoconiosis. (PubMed id 12412984)9 Zhai R....Liang D. (2002)
    154. Biotinylation of interleukin-2 (IL-2) for flow cytometric analysis of IL-2 receptor expression. Comparison of different methods. (PubMed id 7622862)9 De Jong M.O....Visser J.W. (1995)
    155. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. (PubMed id 8060919)9 Furue M....Tamaki K. (1994)
    156. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. (PubMed id 8516819)9 Neuhaus P....Slama K.J. (1993)
    157. The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation. (PubMed id 8318457)9 Perkins G.R....Collins M.K. (1993)
    158. Expression of the interleukin 2 receptor beta chain ( p75) in renal transplantation--applicability of anti-interleukin-2 receptor bet a chain monoclonal antibody. (PubMed id 1831304)9 Niguma T....Orita K. (1991)
    159. Increased soluble interleukin 2 receptor levels in autoimmune thyroid disease. (PubMed id 1683085)9 Nakanishi K....Ohta Y. (1991)
    160. [Vegetative nervous function and interleukin-2 receptor in patients with vertigo] (PubMed id 2379296)9 Luo Z. (1990)
    161. [Effect of bushen huayu composite on secretion of lymphocytic interleukin-2 and interleukin-2 receptor expression in the aged] (PubMed id 12585166)9 Wang R.R. and Liu S.B. (2002)
    162. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. (PubMed id 10887333)9 Nakamura H....Masaoka T. (2000)
    163. Palmitoylation of the p75 neurotrophin receptor has no effect on its interaction with TrkA or on TrkA-mediated down-regulation of cell adhesion molecules. (PubMed id 11020215)9 Vesa J....Shooter E.M. (2000)
    164. Beryllium induces IL-2 and IFN-gamma in berylliosis. (PubMed id 8977230)9 Tinkle S.S....Newman L.S. (1997)
    165. Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. (PubMed id 8089104)9 Evans G.A....Farrar W.L. (1994)
    166. Increased plasma concentrations for type I and II tumor necrosis factor receptors and IL-2 receptors in cancer patients. (PubMed id 8146526)9 Elsasser-Beile U....von Kleist S. (1994)
    167. Interleukin-2 receptor positive cells in human decidua during the first trimester of pregnancy and their association with macrophages. (PubMed id 1533757)9 Kovacs E....Ludwig H. (1992)
    168. Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy. (PubMed id 1477028)9 Lee T.W. and Kim M.J. (1992)
    169. Down-regulation of interleukin-2 receptor expression on natural killer cells/large granular lymphocytes by interleukin-4. (PubMed id 1571094)9 Bosse D. and Ades E. (1992)
    170. Phorbol esters up-regulate p55 and down-regulate p75 expression of interleukin-2 receptors in human T cells. (PubMed id 1581584)9 Onishi R....Uchiyama T. (1992)
    171. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine. (PubMed id 1646506)9 Hess A.D. and Bright E.C. (1991)
    172. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. (PubMed id 1896091)9 Donati D....Raska K. (1991)
    173. [Clinical study on soluble interleukin-2 receptor in patients with sarcoidosis] (PubMed id 1753540)9 Takaishi M....Akiyama M. (1991)
    174. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. (PubMed id 2150086)9 Dumann H....Kohler H. (1990)
    175. Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro. (PubMed id 2111374)9 Dupere S....O'Connor T.E. (1990)
    176. Cleavage of functional IL-2 receptor alpha chain (CD2 5) from murine corneal and conjunctival epithelia by MMP-9. (PubMed id 19878594)9 De Paiva C.S....Pflugfelder S.C. (2009)
    177. The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits. (PubMed id 12467977)9 Kierszenbaum F....Sztein M.B. (2002)
    178. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock. (PubMed id 9892527)9 Nakamura T....Koide H. (1998)
    179. [Effects of lentinan of peripheral blood mononuclear cell expression of interleukin-2 receptor in patients with chronic hepatitis B in vivo and in vitro] (PubMed id 10681809)9 Wan K. (1998)
    180. Quantitation of IL-2Rp75 (CD122) expression on mononuclear cells in rheumatic disease. (PubMed id 8976644)9 Creamer P. and Hall N.D. (1996)
    181. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. (PubMed id 7868294)9 Yang S.X....Long Z.Z. (1994)
    182. Serine-rich region of the IL-2 receptor beta-chain is required for activation of phosphatidylinositol 3-kinase. (PubMed id 8025955)9 Kanazawa T....Varticovski L. (1994)
    183. [A study of T-lymphocyte subsets, IL-2 production and IL-2 receptor expression in peripheral blood lymphocytes in patients with nasopharyngeal carcinoma] (PubMed id 8217300)9 Tan G.L. (1993)
    184. Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levels. (PubMed id 1346344)9 Li B....Suthanthiran M. (1992)
    185. Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins. (PubMed id 2007186)9 Shackelford D.A. and Trowbridge I.S. (1991)
    186. Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. (PubMed id 2037104)9 Nelson L.M....Fleisher T.A. (1991)
    187. Defective interferon gamma production in neonatal T c ells is independent of interleukin-2 receptor binding. (PubMed id 1834981)9 von Freeden U....Burdach S. (1991)
    188. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues. (PubMed id 1691591)9 Hsu S.M....Hsu P.L. (1990)
    189. Interleukin-2 receptor beta-chain (p70-75) expressed on leukemic cells from adult T cell leukemia patients. (PubMed id 2121691)9 Kodaka T....Araki K. (1990)
    190. Defective expression of IL-2 receptors on peripheral blood lymphocytes from patients with cluster headache. (PubMed id 2335478)9 Martelletti P....Rinaldi-Garaci C. (1990)
    191. Histamine blocks interleukin 2 (IL-2) gene expression and regulates IL-2 receptor expression. (PubMed id 2266228)9 Rezai A.R....Kermani-Arab V. (1990)
    192. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. (PubMed id 2228020)9 Polson R.J....Bomford A. (1990)
    193. Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C. (PubMed id 2121373)9 Ioannides C.G....O'Brian C.A. (1990)
    194. Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response. (PubMed id 2394581)9 Guarcello V....Marchetti B. (1990)
    195. Putative gamma-subunit of the IL-2 receptor is detected in low, intermediate, and high affinity IL-2 receptor-bearing cells. (PubMed id 1972716)9 Colamonici O.R....Rosolen A. (1990)
    196. Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease. (PubMed id 2228030)9 Penttila I.A....LaBrooy J.T. (1990)
    197. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells. (PubMed id 2383656)9 Hoshino S....Mizoguchi H. (1990)
    198. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor--a model for human T-cell malignancies expressing IL-2 receptor. (PubMed id 2298500)9 Lugasi H....Naor D. (1990)
    199. Interleukin-2 receptor blockade with humanized monocl onal antibody for solid organ transplantation. (PubMed id 20415630)9 Campara M....Oberholzer J. (2010)
    200. Engineered interleukin-2 antagonists for the inhibiti on of regulatory T cells. (PubMed id 19816193)9 Liu D.V....Wittrup K.D. (2009)
    201. Phenotyping sarcoidosis from a pulmonary perspective. (PubMed id 17975200)9 Prasse A....MA1ller-Quernheim J. (2008)
    202. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. (PubMed id 16996570)9 Odegaard E....Davidson B. (2007)
    203. [Are IL2 receptor antagonist useful in high risk acute tubular necrosis kidney recipients?] (PubMed id 18045028)9 Fernandez A....Zamora J. (2007)
    204. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. (PubMed id 17409595)9 Fukushima N....Eguchi K. (2007)
    205. Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: a report of the NAPRTCS. (PubMed id 16468970)9 Smith J.M....McDonald R.A. (2006)
    206. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. (PubMed id 16596236)9 Ouyang G.F....Takami T. (2006)
    207. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. (PubMed id 15562014)9 Carrillo-Vico A....Guerrero J.M. (2005)
    208. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. (PubMed id 15592670)9 Melder R.J....Gallant G. (2005)
    209. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. (PubMed id 15930520)9 Li Q....Li J. (2005)
    210. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study. (PubMed id 15864608)9 Zbar A.P....Bodmer W.F. (2005)
    211. Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At. (PubMed id 15028248)9 Wesley J.N....Waldmann T.A. (2004)
    212. Role of circulating cytokines and chemokines in exertional heatstroke. (PubMed id 14758154)9 Lu K.C....Lin Y.F. (2004)
    213. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. (PubMed id 15365604)9 Vincenti F. (2004)
    214. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. (PubMed id 15307180)9 de la Rosa M....Scheffold A. (2004)
    215. Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions. (PubMed id 15163192)9 Raimundo B.C....Arkin M.R. (2004)
    216. Defective interleukin-2 production and interleukin-2 receptor expression in pulmonary tuberculosis. (PubMed id 15562950)9 Khanna M....Kumar P. (2003)
    217. The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system. (PubMed id 12628467)9 Nomura J....Nomura Y. (2003)
    218. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. (PubMed id 12716928)9 Bronfman F.C....Fainzilber M. (2003)
    219. Elevated concentrations of soluble IL-2 receptor in b oth bronchoalveolar lavage fluid and serum in a patient with BOOP. (PubMed id 14609262)9 Matsuno O....Kumamoto T. (2003)
    220. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions. (PubMed id 12421238)9 Harita S....Kibata M. (2002)
    221. Maternal serum levels of tumor necrosis factor-alpha and interleukin-2 receptor in threatened abortion: a comparison with normal and pathologic pregnancies. (PubMed id 11591402)9 GA1cer F....Yardim T. (2001)
    222. Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a. (PubMed id 11340297)9 Brockdorff J.L....Odum N. (2001)
    223. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. (PubMed id 11505128)9 Gordon B.R....Rubin A.L. (2001)
    224. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. (PubMed id 11474148)9 Dollner H....Austgulen R. (2001)
    225. CD122 (interleukin-2 receptor beta subunit). (PubMed id 11388752)9 Zamai L....Papa S. (2001)
    226. Serum and ascites fluid cytokine levels in patients with chronic heart failure. (PubMed id 11573826)9 Sari R....Hilmioglu F. (2001)
    227. Complex perioperative immuno-dysfunction in patients with renal cell carcinoma. (PubMed id 11490228)9 BAPhm M....Allhoff E.P. (2001)
    228. The predictive value of serum interleukins in recurrent respiratory papillomatosis: a preliminary study. (PubMed id 11224768)9 Snowden R.T....Stocks R.M. (2001)
    229. T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. (PubMed id 11231343)9 van Riemsdijk I.C....Weimar W. (2001)
    230. Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes. (PubMed id 11600465)9 O'Loughlin E.V....Clancy R. (2001)
    231. Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease. (PubMed id 11288973)9 Simon A.D....Rabbani L.E. (2001)
    232. STAT5 pathway: target of anti-CD4 antibody in attenuation of IL-2 receptor signaling. (PubMed id 11330544)9 Goebel J....Lowry R.P. (2001)
    233. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. (PubMed id 11150007)9 Shearer W.T....Dinges D.F. (2001)
    234. Human amniotic fluid lacks interleukin-2 and interleukin-15 but can interact with the beta-chain of the interleukin-2 receptor. (PubMed id 10712671)9 Searle R.F....Lang A.K. (2000)
    235. Interleukin-4 enhances the in vitro precursor cell recruitment for tumor-specific T lymphocytes in patients with glioblastoma. (PubMed id 10687133)9 Faber C....Heuschling P. (2000)
    236. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape. (PubMed id 10685665)9 Rayman P....Finke J.H. (2000)
    237. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. (PubMed id 10920190)9 Bianchi M....Ivashkiv L.B. (2000)
    238. Soluble TNF and IL-2 receptors in patients with breast cancer. (PubMed id 11208388)9 Tesarova P....Tesar V. (2000)
    239. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. (PubMed id 10944485)9 Prasad A.S. (2000)
    240. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. (PubMed id 10931379)9 Perola O....Pelkonen J. (2000)
    241. B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines. (PubMed id 10749102)9 Prat A....Antel J.P. (2000)
    242. Increased expression of interleukin-4 during liver allograft rejection. (PubMed id 10365823)9 Conti F....Zafrani E.S. (1999)
    243. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. (PubMed id 10397706)9 Maurice M....Cosset F.L. (1999)
    244. Phenotypic analysis and proliferative responses of human endometrial granulated lymphocytes during the menstrual cycle. (PubMed id 10084960)9 Searle R.F....Bulmer J.N. (1999)
    245. Diminished interferon-gamma production in gastric mucosa T lymphocytes after H. pylori eradication in duodenal ulcer patients. (PubMed id 10430335)9 Ihan A....Kopitar A. (1999)
    246. Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study). (PubMed id 10629645)9 Demir G....Berkarda B. (1999)
    247. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. (PubMed id 10359123)9 Kierszenbaum F....Sztein M.B. (1999)
    248. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. (PubMed id 9554296)9 Papi M....Cavalieri R. (1998)
    249. [Soluble TNF and IL-2 receptors in patients with breast carcinoma] (PubMed id 9727208)9 TesarovA! P....Tesar V. (1998)
    250. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. (PubMed id 9060545)9 Du Bois J.S....Atkins M.B. (1997)
    251. Alteration of interleukin-2 (IL-2) and soluble IL-2 receptor secretion in the sera and urine of patients with rickettsial boutonneuse fever. (PubMed id 8985208)9 Mansueto S....Cillari E. (1997)
    252. Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage. (PubMed id 9184320)9 Tatsumi M....Nanko S. (1997)
    253. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. (PubMed id 9274442)9 Mantovani G....Del Giacco G.S. (1997)
    254. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study. (PubMed id 9083163)9 Tartour E....Rodriguez J. (1997)
    255. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands. (PubMed id 9236214)9 Maliartchouk S. and Saragovi H.U. (1997)
    256. Immunohistochemical analysis of the neurotrophins BDNF and NT-3 and their receptors trk B, trk C, and p75 in the developing chick retina. (PubMed id 9364722)9 Das I....Sparrow J.R. (1997)
    257. Influence of some immune factors on the IL-6 and soluble IL-2 receptors in haemodialysed patients. (PubMed id 9285313)9 Koziol/-Montewka M....Przylepa E. (1997)
    258. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor. (PubMed id 9001414)9 Frankel A.E....Tagge E.P. (1997)
    259. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. (PubMed id 9129156)9 Adachi M....Imai K. (1997)
    260. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation. (PubMed id 8704680)9 Arbour S....Roy D.C. (1996)
    261. A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma. (PubMed id 8855983)9 Ahmed F.Y....Gore M.E. (1996)
    262. Effect of rapamycin on the expression of the IL-2 receptor (CD25). (PubMed id 8565319)9 Woerly G....Ryffel B. (1996)
    263. CTLA-4 ligation blocks CD28-dependent T cell activation. (PubMed id 8676075)9 Walunas T.L....Bluestone J.A. (1996)
    264. Flow cytometric characterisation of the 'false naive' (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis. (PubMed id 8853229)9 Neidhart M....BrA1hlmann P. (1996)
    265. Il-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients. (PubMed id 8975986)9 Ihan A....Gubina M. (1996)
    266. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. (PubMed id 8717512)9 Sugamura K....Takeshita T. (1996)
    267. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. (PubMed id 8580378)9 Kirken R.A....Farrar W.L. (1995)
    268. IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. (PubMed id 7612266)9 Minami Y. and Taniguchi T. (1995)
    269. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. (PubMed id 7639234)9 Nielsen O.H....Kirman I. (1995)
    270. Characterization of a monoclonal antibody directed against the NH2 terminal area of interleukin-2 (IL-2) and inhibiting specifically the binding of IL-2 to IL-2 receptor beta chain (IL-2R beta). (PubMed id 8544854)9 Moreau J.L....ThA"ze J. (1995)
    271. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate. (PubMed id 7738942)9 Crilly A....Madhok R. (1995)
    272. Serum neopterin and soluble interleukin-2 receptor for prediction of a shock state in gram-negative sepsis. (PubMed id 7647844)9 Delogu G....Signore L. (1995)
    273. Immunoregulatory effects of a synthetic monosaccharide. (PubMed id 8576539)9 Chang D.M. (1995)
    274. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. (PubMed id 8675621)9 Carson W.E....Caligiuri M.A. (1995)
    275. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain. (PubMed id 7665592)9 Goldsmith M.A....Greene W.C. (1995)
    276. Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain. (PubMed id 7868880)9 Goldsmith M.A....Greene W.C. (1995)
    277. [Effect of epimedium sagittatum on soluble IL-2 receptor and IL-6 levels in patients undergoing hemodialysis] (PubMed id 7796653)9 Chen X....Wang J. (1995)
    278. HIV type 1 protease activation of NF-kappa B within T lymphoid cells. (PubMed id 7742037)9 Zhang D....Byrn R.A. (1995)
    279. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. (PubMed id 8562579)9 Barak V....Roisman I. (1995)
    280. Interleukin-2 binding proteins in sera from normal subjects and multiple sclerosis patients. (PubMed id 7501143)9 Trotter J.L....Cross A.H. (1995)
    281. Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor. (PubMed id 7621867)9 Han D....Azzarone B. (1995)
    282. Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2. (PubMed id 7881967)9 Deehan D.J....Eremin O. (1995)
    283. Imbalance of the interleukin 2 system in children with IDDM. (PubMed id 8056185)9 Tomoda T....Taniguchi T. (1994)
    284. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor. (PubMed id 7807163)9 Ciardi M....Cirelli A. (1994)
    285. Effects of radiolabelled murine antibody infusion on TNF-alpha, IL-1 beta, and soluble IL-2 receptor in cancer patients. (PubMed id 7931817)9 Gridley D.S....Slater J.M. (1994)
    286. Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. (PubMed id 8202660)9 Toussirot E....Acquaviva P.C. (1994)
    287. Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study. (PubMed id 8080984)9 Foss F.M....Woodworth T. (1994)
    288. Growth regulation of a T-cell lymphoma via the T-cell receptor. (PubMed id 8289463)9 O'Neill H.C. (1994)
    289. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes. (PubMed id 8198969)9 Trentin L....Semenzato G. (1994)
    290. Chemoattractant activity of IL-2 for human lymphocytes: a requirement for the IL-2 receptor beta-chain. (PubMed id 8045589)9 Wilkinson P.C. and Newman I. (1994)
    291. Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro. (PubMed id 7954524)9 Scheid C....Stern P.L. (1994)
    292. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. (PubMed id 8291216)9 Kishikawa H....Watanabe T. (1993)
    293. Evidence for an ongoing role of class I histocompatibility molecules for the production of interleukin-2 in response to suboptimal concentrations of phytohaemagglutinin. (PubMed id 8484101)9 Hashimoto S....Michalski J.P. (1993)
    294. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes. (PubMed id 8102412)9 Maguer V....Dodon M.D. (1993)
    295. [Characterization of autologous-tumor specific cytotoxic T cells induced by means of butanol-extracted soluble antigen from T lymphocytes in colon cancer patients] (PubMed id 8464410)9 Hamagashira K. (1993)
    296. Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: possible role in hypercalcemia associated with adult T cell leukemia. (PubMed id 8099324)9 Ikeda K....Matsumoto T. (1993)
    297. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. (PubMed id 7889544)9 Mantovani G....Pusceddu G. (1993)
    298. Affinity purification and characterization of anti-Ta c(Fv)-C3-PE38KDEL: A highly potent cytotoxic agent specific to cells bearing IL -2 receptors. (PubMed id 8431514)9 Spence C....Bailon P. (1993)
    299. Upregulation by retinoic acid of interleukin-2-recept or mRNA in human T lymphocytes. (PubMed id 7678784)9 Sidell N....Bhatti L. (1993)
    300. Immune stimulatory and anti-tumour properties of haemin. (PubMed id 8370158)9 Tsuji A....Novogrodsky A. (1993)
    301. Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term. (PubMed id 8395036)9 Austgulen R....Espevik T. (1993)
    302. Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells. (PubMed id 8335371)9 Mintz C.S....Malek T. (1993)
    303. Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies. (PubMed id 8468587)9 Ciardi M....Cirelli A. (1993)
    304. [Cytokine levels in patients with thrombotic thrombocytopenic purpura] (PubMed id 7679449)9 Wada H....Shirakawa S. (1993)
    305. [Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states] (PubMed id 8303976)9 Mazur G. and Frydecka I. (1993)
    306. Pregnancy-associated, lymphocyte-derived suppressor factor inhibits protein kinase C activity. (PubMed id 8229996)9 Blumenthal E.J....Hoversland R.C. (1993)
    307. Analysis of high and low responses to Staphylococcus aureus and interleukin 2 in human B lymphocytes. (PubMed id 8288726)9 Peckham D.W....Ashman R.F. (1993)
    308. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis. (PubMed id 8423463)9 Sharief M.K....Thompson E.J. (1993)
    309. Selection of internalization-deficient cells by inter leukin-2-Pseudomonas exotoxin chimeric protein: the cytoplasmic domain of the i nterleukin-2 receptor beta chain does not contribute to internalization of inte rleukin-2. (PubMed id 8258333)9 Furse R.K. and Malek T.R. (1993)
    310. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi? (PubMed id 8288318)9 Kierszenbaum F....Sztein M.B. (1993)
    311. Impaired T cell functions during amphibian metamorpho sis: IL-2 receptor expression and endogenous ligand production. (PubMed id 1498041)9 Ruben L.N....Balls M. (1992)
    312. Tumor recognition and lytic competence of IL-2-activated lymphocytes: regulation of both antibody-independent and -dependent cellular cytotoxicity via P75 IL-2 receptor. (PubMed id 1420599)9 Lagoo-Deenadayalan S....Grimm E.A. (1992)
    313. Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HI V-1) infection. (PubMed id 1430108)9 Zambello R....Semenzato G. (1992)
    314. Effects of surgical trauma on interleukin 2 production and interleukin 2 receptor expression. (PubMed id 1453505)9 Li H....Luo Y. (1992)
    315. Structure and function of IL-2 and IL-2 receptors. (PubMed id 1524574)9 Taniguchi T. (1992)
    316. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. (PubMed id 1500859)9 Voss S.D....Robb R.J. (1992)
    317. c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain. (PubMed id 1549560)9 Hatakeyama M....Taniguchi T. (1992)
    318. Interleukin 2-induced activation of Ras requires two domains of interleukin 2 receptor beta subunit, the essential region for growth stimulation and Lck-binding domain. (PubMed id 1460037)9 Satoh T....Kaziro Y. (1992)
    319. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro--its implication in the pathogenesis of adult T cell leukemia (ATL). (PubMed id 1419953)9 Maeda M. (1992)
    320. The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75). (PubMed id 1565844)9 Scheibenbogen C....Hunstein W. (1992)
    321. CD2-mediated autocrine growth of herpes virus saimiri -transformed human T lymphocytes. (PubMed id 1355105)9 MittrA1cker H.W....Fleischer B. (1992)
    322. Plasma cytokine levels in thrombotic thrombocytopenic purpura. (PubMed id 1609769)9 Wada H....Shirakawa S. (1992)
    323. Decreased interleukin-2 receptor beta chain expressio n by peripheral blood lymphocytes in chronic liver disease. (PubMed id 1325198)9 Masumoto T....Ohta Y. (1992)
    324. Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis. (PubMed id 1390170)9 Hunziker T....Braathen L.R. (1992)
    325. [A study about the ability of interleukin-2 production, interleukin-2 receptor expression by lymphocytes from patients with lung cancer] (PubMed id 1339618)9 Liu S.B. (1992)
    326. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. (PubMed id 1606739)9 Hofmann B....Fahey J.L. (1992)
    327. [Pathogenesis of T-lymphocyte alveolitis associated with HTLV-I infection] (PubMed id 1630041)9 Sugimoto M. (1992)
    328. Adenosine deaminase activity and free IL-2 receptor levels in serum from patients with mycoplasma pneumonia. (PubMed id 1907690)9 Suga M....Araki S. (1991)
    329. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. (PubMed id 1864009)9 Matsumoto T....Yodoi J. (1991)
    330. Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment. (PubMed id 1910217)9 Tiberghien P....Herve P. (1991)
    331. [Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2)] (PubMed id 1836210)9 Wustrow T.P. (1991)
    332. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. (PubMed id 1713578)9 Remillard B....Varticovski L. (1991)
    333. The role of glutathione in lymphocyte activation--II. Effects of buthionine sulfoximine and 2-cyclohexene-1-one on early and late activation events. (PubMed id 1709148)9 Hamilos D.L....Wedner H.J. (1991)
    334. Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy. (PubMed id 1915444)9 Hufnagel G. and Maisch B. (1991)
    335. The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662). (PubMed id 1750068)9 Weir M.R....Moran M.A. (1991)
    336. The immunosuppressive agent FK506 inhibits in vitro e xpression of membrane-bound and soluble interleukin-2 receptors on resting but not on activated human lymphocytes. (PubMed id 1720417)9 Karlsson H....NAossberger L. (1991)
    337. Influence of growth hormone-releasing hormone (GHRH) on phytohemagglutinin-induced lymphocyte activation: comparison of two synthetic forms. GHRH and PHA-induced lymphocyte activation. (PubMed id 1833862)9 Valtorta A....Severi F. (1991)
    338. Negative regulation of interleukin-2 production in primary lymphocytes by 12-O-tetradecanoylphorbol-13-acetate. (PubMed id 1715761)9 Mastro A.M....Pishak S.A. (1991)
    339. Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. (PubMed id 2045128)9 Starkey P.M. (1991)
    340. Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. (PubMed id 1673434)9 Plana M....Vives J. (1991)
    341. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. (PubMed id 2067197)9 Zaoui P....Hakim R.M. (1991)
    342. Effects of hyperlipaemic serum on interleukin-2 (IL-2 ) production, IL-2 receptor expression, and T cell proliferation induced by IL- 2 in cynomolgus monkeys. (PubMed id 1875552)9 Terao K. and Fukase Y. (1991)
    343. Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation. (PubMed id 1768652)9 Molitor J.A....Greene W.C. (1991)
    344. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes. (PubMed id 1835747)9 Zambello R....Pizzolo G. (1991)
    345. Regulation of the interleukin 2 receptor complex tyrosine kinase activity in vitro. (PubMed id 1751780)9 Michiel D.F....Farrar W.L. (1991)
    346. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients. (PubMed id 1999955)9 Cimino G....Mandelli F. (1991)
    347. Soluble IL-2 receptor and CD25 cells in psoriasis: ef fects of cyclosporin A and PUVA therapy. (PubMed id 1864010)9 Duncan J.I....Thomson A.W. (1991)
    348. Fibronectin augments anti-CD3-mediated IL-2 receptor (CD25) expression on human peripheral blood lymphocytes. (PubMed id 1826861)9 Cardarelli P.M....Morgan E.L. (1991)
    349. Biochemical evidence for a third chain of the interleukin-2 receptor. (PubMed id 1939240)9 Saito Y....Honjo T. (1991)
    350. Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor. (PubMed id 1879969)9 Starkebaum G....Ruscetti F.W. (1991)
    351. Elevation of cyclic adenosine monophosphate levels independently down regulates IL-1, IL-2, and IL-2 receptor (CD25) syntheses. (PubMed id 2177038)9 Iwaz J....Revillard J.P. (1990)
    352. [Study on adoptive immunotherapy on patients with renal cell carcinoma. I. Functional characteristics of peripheral blood mononuclear cells and serum immunosuppressive factors in patients with renal cell carcinoma] (PubMed id 2214468)9 Usui A. (1990)
    353. Regulatory effects of IL-4 on human B-cell response to IL-2. (PubMed id 2102812)9 Galanaud P....Llorente L. (1990)
    354. Regulation of expression of interleukin 2 receptors upon triggering of the TCR-CD3 complex on human T lymphocytes. (PubMed id 2145219)9 Kabouridis P.S. and Tsoukas C.D. (1990)
    355. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets. (PubMed id 1707657)9 Nishikawa K....Sugamura K. (1990)
    356. Immunological abnormalities in HTLV-I-associated myelopathy: spontaneous release of interleukin-2 and interleukin-2 receptor by peripheral blood lymphocytes. (PubMed id 1982452)9 Li Q....Araki S. (1990)
    357. Soluble interleukin 2 receptors in autoimmune chronic active hepatitis. (PubMed id 2379874)9 Lobo-Yeo A....Vergani D. (1990)
    358. Selective expression of the p70 subunit of the interleukin-2 receptor on lymphocytes from patients with infectious mononucleosis. (PubMed id 2295000)9 Kamio M....Yamaguchi N. (1990)
    359. Immunogenic epitopes of the p55 chain of the IL-2 rec eptor. Relationships to high-affinity IL-2 binding and modulation of the p55 ch ain. (PubMed id 1690471)9 Wong J.T....Colvin R.B. (1990)
    360. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. (PubMed id 2139697)9 Nagler A....Phillips J.H. (1990)
    361. Interleukin 2 (IL 2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels. (PubMed id 2338453)9 Miossec P....Hirn M. (1990)
    362. Stimulation of the antigen and interleukin-2 receptors on T lymphocytes activates distinct tyrosine protein kinases. (PubMed id 2351654)9 Saltzman E.M....Casnellie J.E. (1990)
    363. Effect of tumor-derived immunosuppressive factor(s) on interleukin 2 and on expression of interleukin 2 receptor. (PubMed id 2348488)9 Wang R.D....Chen Z.C. (1990)
    364. Simultaneous evaluation of membrane bound and soluble interleukin 2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritis. (PubMed id 2289327)9 Vaisberg M. and Scheinberg M.A. (1990)
    365. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. (PubMed id 1692080)9 Caligiuri M.A....Ritz J. (1990)
    366. Combined immunodeficiency due to the selective absence of CD4 inducer T lymphocytes. (PubMed id 1971201)9 Sleasman J.W....Barrett D.J. (1990)
    367. Different activation states of human lymphocytes after antibody-mediated stimulation via CD3 and the alpha/beta T-cell receptor. (PubMed id 2148645)9 Schlitt H.J....Wonigeit K. (1990)
    368. Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus. (PubMed id 12630754)9 Daza L....Moreno J. (2003)
    369. Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys. (PubMed id 11359452)9 Brok H.P....'t Hart B.A. (2001)
    370. The IL-2 receptor present on human embryonic fibroblasts is functional in the absence of P64/IL-2R gamma chain. (PubMed id 8104471)9 Plaisance S....Azzarone B. (1993)
    371. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. (PubMed id 19236436)9 Hammond E.B....Baliga P.K. (2010)
    372. Monocyte IL-2Ralpha expression is associated with thr ombosis and the JAK2V617F mutation in myeloproliferative neoplasms. (PubMed id 20483636)9 Goette N.P....Marta R.F. (2010)
    373. Disengaging the IL-2 receptor with daclizumab enhance s IL-7-mediated proliferation of CD4(+) and CD8(+) T cells. (PubMed id 19788505)9 Monti P....Bonifacio E. (2009)
    374. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). (PubMed id 19125193)9 Alcina A....Matesanz F. (2009)
    375. Greater posttransplant inflammation and oxidation are associated with worsening kidney function in patients with pretransplant diabe tes mellitus. (PubMed id 19715851)9 Morales-Indiano C....Romero R. (2009)
    376. The genetics of autoimmune thyroid disease. (PubMed id 19343617)9 Weetman A.P. (2009)
    377. Phase I/II open-label study of the biologic effects o f the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with me tastatic malignant melanoma. (PubMed id 19640287)9 Ribas A....Morse M.A. (2009)
    378. [Clinical values of biomarkers in hematopoietic malignancies] (PubMed id 19151562)9 Kawaguchi T. and Nosaka K. (2009)
    379. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. (PubMed id 19155502)9 Maier L.M....Hafler D.A. (2009)
    380. Hepcidin and iron deficiency in pre-kidney transplant patients. (PubMed id 19715836)9 Sancho A....Romero R. (2009)
    381. [Medical study of 69 cases diagnosed as Kikuchi's dis ease] (PubMed id 19697871)9 Nakamura I....Ajisawa A. (2009)
    382. Extended daclizumab monotherapy for rejection-free su rvival in non-adherent adolescent recipients of renal allografts. (PubMed id 19017291)9 Chaudhuri A....Sarwal M.M. (2009)
    383. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipi ents. (PubMed id 19660021)9 Busque S....Chan G. (2009)
    384. IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. (PubMed id 18990450)9 DurAc M. and Macian F. (2009)
    385. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. (PubMed id 19846277)9 Barak V....Shoenfeld Y. (2009)
    386. Outcomes of patients with severe combined immunodefic iency treated with hematopoietic stem cell transplantation with and without pre conditioning. (PubMed id 19895994)9 Patel N.C....Shearer W.T. (2009)
    387. Diffuse large B-cell lymphoma presenting with hypoglossal nerve palsy and great occipital neuralgia. (PubMed id 19265306)9 Kanai Y....Itagaki N. (2009)
    388. IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. (PubMed id 19210506)9 Kordasti S.Y....Mufti G.J. (2009)
    389. Relation of bone mineral density with clinical and la boratory parameters in pre-pubertal children with cystic fibrosis. (PubMed id 19504563)9 Cobanoglu N....Gocmen A. (2009)
    390. Equivalent outcomes with primary and retransplantatio n in African-American deceased-donor renal allograft recipients. (PubMed id 19789023)9 Gruber S.A....Doshi M.D. (2009)
    391. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. (PubMed id 18787222)9 Busse W.W....Shames R.S. (2008)
    392. Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. (PubMed id 18235249)9 Zeiser R. and Negrin R.S. (2008)
    393. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. (PubMed id 18609101)9 Bargagli E....Rottoli P. (2008)
    394. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. (PubMed id 18189187)9 WAYllberg-Jonsson S....RantapAoAo-Dahlqvist S. (2008)
    395. Clathrin-dependent and independent endocytosis of glucose transporter 4 (GLUT4) in myoblasts: regulation by mitochondrial uncoupling. (PubMed id 18435821)9 Antonescu C.N....Klip A. (2008)
    396. Cytokines and their receptors as biomarkers of systemic lupus erythematosus. (PubMed id 18366305)9 Suh C.H. and Kim H.A. (2008)
    397. Ghrelin as an acute-phase reactant during postoperative stress response. (PubMed id 18404598)9 Maruna P....Rosicka M. (2008)
    398. Psychological stress, endocrine and immune response in patients with lichen planus. (PubMed id 18986442)9 Krasowska D....RoliA8ski J. (2008)
    399. Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis. (PubMed id 18507862)9 Prahalad S....Hill H.R. (2008)
    400. Comparative methodologies of regulatory T cell deplet ion in a murine melanoma model. (PubMed id 18295790)9 Matsushita N....Riker A.I. (2008)
    401. Human facial allotransplantation: a 2-year follow-up study. (PubMed id 18722867)9 Guo S....Li H. (2008)
    402. Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient. (PubMed id 18339148)9 Kaplan B....Oberholzer J. (2008)
    403. (123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma. (PubMed id 17929011)9 Loose D....Van de Wiele C. (2008)
    404. Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix. (PubMed id 19245171)9 Mindiola R....Mosquera J. (2008)
    405. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. (PubMed id 18192240)9 Tuomisto T.T....Yla-Herttuala S. (2008)
    406. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. (PubMed id 18005941)9 Potvin S....Kouassi E. (2008)
    407. Denileukin diftitox for the treatment of cutaneous T- cell lymphoma. (PubMed id 19707452)9 Kaminetzky D. and Hymes K.B. (2008)
    408. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. (PubMed id 18477227)9 Serhat Inaloz H....Tarakcioglu M. (2008)
    409. A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex. (PubMed id 17000002)9 Volkland J....Pflanz S. (2007)
    410. Rethinking the triggering inflammatory processes of chronic periaortitis. (PubMed id 17108706)9 Meier P....Blanc E. (2007)
    411. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. (PubMed id 17571248)9 Amato R....Perrotti N. (2007)
    412. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones. (PubMed id 17541281)9 Kajiyama Y....Mori A. (2007)
    413. Daclizumab. (PubMed id 17916050)9 Mottershead M. and Neuberger J. (2007)
    414. Allele-sharing of cytokine genes in familial inflammatory bowel disease. (PubMed id 17708278)9 van der Linde Rooij F.W. (2007)
    415. Alemtuzumab induction and recurrence of glomerular di sease after kidney transplantation. (PubMed id 17565315)9 Pascual J....Samaniego M.D. (2007)
    416. Cells with haematopoietic stem cell phenotype in adult human endometrium: relevance to infertility? (PubMed id 17208945)9 Lynch L....O'Farrelly C. (2007)
    417. Interleukin-2 receptor beta chain locus rearrangement in a T-cell acute lymphoblastic leukemia. (PubMed id 16697123)9 Berger R. and Bernard O.A. (2007)
    418. The role of basiliximab induction therapy in organ transplantation. (PubMed id 17150025)9 Ramirez C.B. and Marino I.R. (2007)
    419. CD25-expressing B-lymphocytes in rheumatic diseases. (PubMed id 17257224)9 Amu S....Brisslert M. (2007)
    420. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. (PubMed id 17220337)9 Linkov F....Ferris R.L. (2007)
    421. [Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus] (PubMed id 18186231)9 Oki E....Tanaka H. (2007)
    422. Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment. (PubMed id 17536016)9 Hsu C.L....Kondo M. (2007)
    423. Induction therapy in pediatric renal transplant recipients: an overview. (PubMed id 17927304)9 Moudgil A. and Puliyanda D. (2007)
    424. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease. (PubMed id 17302896)9 Baker C....Dayan C.M. (2007)
    425. Malignancies of the colorectum and anus in solid orga n recipients. (PubMed id 17343685)9 Aigner F....Bonatti H. (2007)
    426. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. (PubMed id 17699323)9 Gallon L.G....Kaufman D.B. (2006)
    427. Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. (PubMed id 17105418)9 Quan W.D....Liles D.K. (2006)
    428. A study of the effect of salicylic acetic acid on a lymphocyte cell model of cellular activation and proliferation. (PubMed id 16011873)9 Aguilar E.A....MuA+oz E. (2006)
    429. CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma. (PubMed id 16410787)9 Talpur R....Duvic M. (2006)
    430. Intestinal transplantation in The Netherlands: first experience and future perspectives. (PubMed id 16782621)9 Dijkstra G....Ploeg R.J. (2006)
    431. Daclizumab for children with corticosteroid refractory graft-versus-host disease. (PubMed id 16247417)9 Teachey D.T....Bunin N. (2006)
    432. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy. (PubMed id 16699371)9 Liu S....Parkhurst M. (2006)
    433. Immunosuppression in pediatric solid organ transplant ation: opportunities, risks, and management. (PubMed id 17096754)9 Tredger J.M....Dhawan A. (2006)
    434. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus. (PubMed id 16699373)9 Mikhailova A.A....Petrov R.V. (2006)
    435. Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial. (PubMed id 17031403)9 Klatte T....BAPhm M. (2006)
    436. Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMikbeta(1)), and correlation with functional activity using an antigen-transfected murine cell line. (PubMed id 16564055)9 Yang X.Y....Soman G. (2006)
    437. A novel IL2RG mutation associated with maternal T lymphocyte engraftment in a patient with severe combined immunodeficiency. (PubMed id 16601912)9 Kellermayer R....Puck J.M. (2006)
    438. Cytokine alterations in lichen sclerosus: an immunohistochemical study. (PubMed id 17034521)9 Farrell A.M....Wojnarowska F. (2006)
    439. [A case of granulomatous orchitis] (PubMed id 17131875)9 Tomita Y. and Nemoto K. (2006)
    440. Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines. (PubMed id 17100778)9 Tsukamoto K....Sharma V. (2006)
    441. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. (PubMed id 17194640)9 Himmerich H....PollmAocher T. (2006)
    442. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. (PubMed id 16407117)9 Hsu C.L....Kondo M. (2006)
    443. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. (PubMed id 17101596)9 Aarstad H.J....Ulvestad E. (2006)
    444. Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation. (PubMed id 17112887)9 Perez-Villa F....Roig E. (2006)
    445. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis. (PubMed id 17014006)9 Weisman M.H....Moreland L.W. (2006)
    446. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. (PubMed id 16547946)9 Bulfone-Paus S....Paus R. (2006)
    447. Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen. (PubMed id 17098001)9 AgA1ero J....Salvador A. (2006)
    448. Transient ischemia-induced changes of interleukin-2 and its receptor beta immunoreactivity and levels in the gerbil hippocampal CA1 region. (PubMed id 16814753)9 Hwang I.K....Won M.H. (2006)
    449. Apoptosis of allospecifically activated human helper T cells is blocked by calcineurin inhibition. (PubMed id 16431291)9 Woodside K.J....Daller J.A. (2006)
    450. Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation. (PubMed id 16635746)9 Nomura S....Hayashi K. (2006)
    451. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. (PubMed id 17058261)9 Wakabayashi K....Gershwin M.E. (2006)
    452. Phase II clinical studies of denileukin diftitox diph theria toxin fusion protein in patients with previously treated chronic lymphoc ytic leukemia. (PubMed id 16586495)9 Frankel A.E....Cripe L.D. (2006)
    453. [Small bowel transplantation as a treatment option fo r intestinal failure in children and adults] (PubMed id 15751317)9 Dijkstra G....Ploeg R.J. (2005)
    454. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. (PubMed id 16138102)9 Leonard W.J. and Spolski R. (2005)
    455. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy. (PubMed id 16115526)9 Verra N....Vyth-Dreese F. (2005)
    456. Intrathecal chemotherapy for patients with meningeal carcinomatosis. (PubMed id 15639526)9 Yoshida S. and Morii K. (2005)
    457. Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain. (PubMed id 16207471)9 Goebel J....Wills-Karp M. (2005)
    458. Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. (PubMed id 15979891)9 Lapolla A....Plebani M. (2005)
    459. The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy. (PubMed id 16171665)9 Wang G....Morita S. (2005)
    460. Renal cells express a functional interleukin-15 receptor. (PubMed id 15671076)9 Tejman-Yarden N....Douvdevani A. (2005)
    461. Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level. (PubMed id 15942227)9 Nakashima H....Tamaki K. (2005)
    462. On the role of sIL-2R measurements in rheumatoid arthritis and cancers. (PubMed id 16106097)9 Witkowska A.M. (2005)
    463. Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123. (PubMed id 15528977)9 Si M.S....Borie D.C. (2005)
    464. [Neurohormones and cytokines in heart failure. Correlation with coronary flow reserve] (PubMed id 16324580)9 Coma-Canella I....SA!nchez Ibarrola A. (2005)
    465. Immunomodulatory compounds from Pestalotiopsis leucothA9 Kumar D.S....Hyde K.D. (2005)
    466. Prevention and treatment of rejection after simultane ous pancreas-kidney transplantation. (PubMed id 16261897)9 Yang L....Li G.C. (2005)
    467. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia. (PubMed id 16254256)9 Lee W....Han K. (2005)
    468. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. (PubMed id 16088321)9 LuczyA8ski W....Malinowska I. (2005)
    469. Excellent results with calcineurin inhibitor-free ini tial immunosuppression in old recipients of old kidneys. (PubMed id 15848563)9 BAPsmA1ller C....Margreiter R. (2005)
    470. [An adult case of precursor B cell lymphoblastic lymphoma extending from right neck to upper cervical spinal region] (PubMed id 16277225)9 Nishihara M....Kohmura E. (2005)
    471. Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease. (PubMed id 16019456)9 Lunn R.A....Treleaven J. (2005)
    472. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure. (PubMed id 15678692)9 Meier P....Blanc E. (2005)
    473. DNA microarray-based gene expression profiles of cytomegalovirus infection and acute rejection in liver transplants. (PubMed id 15848677)9 Inkinen K....Lautenschlager I. (2005)
    474. Serum cytokine changes in Turkish children infected with Giardia lamblia with and without allergy: Effect of metronidazole treatment. (PubMed id 15979046)9 Bayraktar M.R....Durmaz R. (2005)
    475. Treatment of steroid-resistant acute graft-versus-hos t disease with daclizumab and etanercept. (PubMed id 15806135)9 Wolff D....Freund M. (2005)
    476. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. (PubMed id 15605075)9 Bian H....Schirrmacher V. (2005)
    477. L-arginine effects on myocardial stress in cardiac surgery: preliminary results. (PubMed id 16320926)9 Colagrande L....Paolini G. (2005)
    478. [Immunoregulatory disorders in chronic sinusitis in patients with atopy] (PubMed id 16358839)9 Stankiewicz W....Jurkiewicz D. (2005)
    479. Increased IL-16 levels in hemophagocytic lymphohistiocytosis. (PubMed id 15342983)9 Takada H....Hara T. (2004)
    480. Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma. (PubMed id 15353540)9 Dang N.H....Fayad L. (2004)
    481. BK nephropathy in kidney transplant recipients treate d with a calcineurin inhibitor-free immunosuppression regimen. (PubMed id 15575919)9 Lipshutz G.S....Vincenti F. (2004)
    482. Hemophagocytic syndrome associated with CD8 positive T-cell chronic lymphocytic leukemia. (PubMed id 15061221)9 Ando K....Ohyashiki K. (2004)
    483. Vascular complications of pancreas transplantation. (PubMed id 15097859)9 Delis S....Ciancio G. (2004)
    484. [Mantle cell lymphoma markedly infiltrated into adrenal glands with adrenal insufficiency] (PubMed id 15359915)9 Hashimoto R....Mori M. (2004)
    485. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. (PubMed id 15726915)9 KoAsyigit Y....Akkus Z. (2004)
    486. Redox status and immune function in type I diabetes families. (PubMed id 15147359)9 Matteucci E....Giampietro O. (2004)
    487. Candida albicans-induced inflammatory response in human keratinocytes. (PubMed id 15189182)9 Wollina U....Hipler U.C. (2004)
    488. Markedly elevated levels of inflammatory cytokines in maternal serum and peritoneal washing during arrested labor. (PubMed id 15005783)9 Abramov Y....Barak V. (2004)
    489. Anti-cytokine therapy for the treatment of graft-vers us-host disease. (PubMed id 15078135)9 Jacobsohn D.A. and Vogelsang G.B. (2004)
    490. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. (PubMed id 15471828)9 Signore A....Calvieri S. (2004)
    491. Serological immunomarkers in cutaneous T cell lymphoma. (PubMed id 15539892)9 Hassel J.C....Dummer R. (2004)
    492. Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma. (PubMed id 15292059)9 Mitra-Kaushik S....Ratner L. (2004)
    493. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. (PubMed id 15450049)9 Yeh S.S....Schuster M.W. (2004)
    494. [Effect of EM201, an in vivo metabolite of erythromyc in (EM), on signal transduction of IL-2 receptor] (PubMed id 16108608)9 Osawa M....Akagawa K. (2004)
    495. Evolution of immunosuppression in liver transplantati on: contribution of cyclosporine. (PubMed id 15041353)9 Furukawa H. and Todo S. (2004)
    496. Effects of lornoxicam on the physiology of severe sepsis. (PubMed id 15566594)9 MemiA9 D....PamukAsu Z. (2004)
    497. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15Ralpha chain. (PubMed id 15123770)9 Ratthe C. and Girard D. (2004)
    498. The carbohydrate recognition by cytokines modulates t heir physiological activities. (PubMed id 15467395)9 Yamashita K. and Fukushima K. (2004)
    499. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases. (PubMed id 15249910)9 Leonardi S....La Rosa M. (2004)
    500. Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody. (PubMed id 15041394)9 Praditpornsilpa K....Tungsanga K. (2004)
    501. Immunosuppression use in renal transplantation from A sian transplant centers: a preliminary report from the Asian Transplant Registr y. (PubMed id 15518679)9 Vathsala A. (2004)
    502. [Host immunity in colorectal cancer patients treated with low-dose Leucovorin plus 5-fluorouracil] (PubMed id 15553714)9 Kobayashi R....Ogawa K. (2004)
    503. Transplant immunology. (PubMed id 14523805)9 Aw M.M. (2003)
    504. Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. (PubMed id 12954628)9 Kotturi M.F....Jefferies W.A. (2003)
    505. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. (PubMed id 14581351)9 Kuniyasu H....Fidler I.J. (2003)
    506. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? (PubMed id 14583663)9 Hoffmann U....KrAomer B.K. (2003)
    507. T cell anergy. (PubMed id 12471050)9 Schwartz R.H. (2003)
    508. Differential gene expression of cytokine and cell surface molecules in T cell subpopulation derived from mammary gland secretion of cows. (PubMed id 14750552)9 Asai K....Kumagai K. (2003)
    509. Investigation of the immunostimulatory properties of oxihumate. (PubMed id 12710739)9 JoonAc G.K....van Rensburg C.E. (2003)
    510. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. (PubMed id 12915736)9 Heredia A....Redfield R.R. (2003)
    511. Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R. (PubMed id 14629624)9 Hedfors I.A. and Brinchmann J.E. (2003)
    512. Immune system alterations in lung cancer patients. (PubMed id 12797908)9 Mazzoccoli G....Perfetto F. (2003)
    513. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). (PubMed id 12943870)9 Cesari M....Pahor M. (2003)
    514. Interleukin-2 receptor-directed therapies for cutaneous lymphomas. (PubMed id 14710895)9 Foss F.M. and Waldmann T.A. (2003)
    515. Cytokine production patterns and antibody response to measles vaccine. (PubMed id 12922130)9 Ovsyannikova I.G....Poland G.A. (2003)
    516. Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients. (PubMed id 12598772)9 Ostrowski S.R....Ullum H. (2003)
    517. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy. (PubMed id 12973028)9 Fumagalli L.A....Nespoli A. (2003)
    518. New developments in allotransplant immunology. (PubMed id 14633790)9 Barrett A.J....Chao N. (2003)
    519. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma. (PubMed id 15314957)9 Chodorowska G. and Czelej D. (2003)
    520. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma. (PubMed id 12779014)9 BAPhm M....Allhoff E.P. (2003)
    521. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis. (PubMed id 12673891)9 Klimiuk P.A....Chwiecko J. (2003)
    522. Activation of human intraepithelial lymphocytes reduces CD3 expression. (PubMed id 12780688)9 Ebert E.C. (2003)
    523. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. (PubMed id 12608932)9 Wakelkamp I.M....Prummel M.F. (2003)
    524. Impact of acute vivax malaria on the immune system and viral load of HIV-positive subjects. (PubMed id 14687465)9 Chen X....Zhang Z. (2003)
    525. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. (PubMed id 14571788)9 Kitaoka S....Kawasaki H. (2003)
    526. Serum cytokine profiles in patients with adult onset Still's disease. (PubMed id 14677188)9 Choi J.H....Park H.S. (2003)
    527. Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. (PubMed id 12901854)9 Ege T....Duran E. (2003)
    528. [Kidney transplantation in Germany - 2002] (PubMed id 14628230)9 Lutz J....Heemann U. (2003)
    529. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma. (PubMed id 15314956)9 Czelej D....Lechowska-Mazur I. (2003)
    530. IL-2 receptor blockers in liver transplantation: init ial experience with daclizumab in Chile. (PubMed id 14612001)9 Innocenti F....Rius M. (2003)
    531. Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis. (PubMed id 12915745)9 Homolka J....MA1ller-Quernheim J. (2003)
    532. Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. (PubMed id 12654830)9 Rogers P.D....McDaniel L.S. (2003)
    533. A case of intravascular large B-cell lymphoma with mu ltiple organ involvement. (PubMed id 14739519)9 Yanagihori H....Kaneko F. (2003)
    534. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. (PubMed id 12733143)9 Lauta V.M. (2003)
    535. Cholesterol and interleukin-6 concentrations relate to outcomes in burn-injured patients. (PubMed id 12792232)9 Vanni H.E....Parker T.S. (2003)
    536. [Influence of erythromycin and the metabolite, EM201 on IL-2 receptor signaling] (PubMed id 14679762)9 Osawa T....Akagawa K. (2003)
    537. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites. (PubMed id 12231477)9 Imbert V....Nabholz M. (2002)
    538. Systemic immune parameters and sleep after ultra-low dose administration of IL-2 in healthy men. (PubMed id 12480497)9 Lange T....Born J. (2002)
    539. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. (PubMed id 12414777)9 Monsalve-De Castillo F....Callejas D. (2002)
    540. Activation of the inflammatory response system in autism. (PubMed id 11803234)9 Croonenberghs J....Maes M. (2002)
    541. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure. (PubMed id 12170032)9 Rumalla V.K....Lowry S.F. (2002)
    542. Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients. (PubMed id 12414758)9 Cuchacovich M....Gonzalez-Gronow M. (2002)
    543. Immunosuppressive and anticancer effect of a mammalian ribonuclease that targets high-affinity interleukin-2-receptors. (PubMed id 12022372)9 Yamamura T....Kitajima M. (2002)
    544. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. (PubMed id 12193748)9 McDyer J.F....Ragheb J.A. (2002)
    545. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. (PubMed id 11964300)9 Gray C.P....Hersey P. (2002)
    546. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. (PubMed id 11929336)9 Jacobsohn D.A. and Vogelsang G.B. (2002)
    547. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. (PubMed id 12499902)9 McNeel D....Buzyn A. (2002)
    548. [An elderly non-Hodgkin lymphoma patient with a massive tumor of the heart] (PubMed id 12229122)9 Hasegawa Y....Yoshida K. (2002)
    549. Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity. (PubMed id 12453470)9 Eisenman J....Park L.S. (2002)
    550. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2. (PubMed id 12015902)9 Fortis C....Poli G. (2002)
    551. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. (PubMed id 11988817)9 Doganay S....Savli H. (2002)
    552. Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer. (PubMed id 11915173)9 Berghella A.M....Adorno D. (2002)
    553. Analysis of host response to hepatectomy by simultaneous measurement of cytokines in the portal vein, caval vein and radial artery. (PubMed id 12449519)9 Kanaoka Y....Tanaka N. (2002)
    554. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. (PubMed id 12200381)9 Sereti I....Lane H.C. (2002)
    555. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. (PubMed id 11988666)9 Hensler T....Neugebauer E.A. (2002)
    556. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. (PubMed id 12006434)9 Tanaka H....Abe S. (2002)
    557. [Cytokines and soluble cytokine receptors in the perioperative period] (PubMed id 12688152)9 Maruna P....PeskovA! M. (2002)
    558. Interleukin-2 inhibits proliferation of HPV-associated tumor cells and halts tumor growth in vivo. (PubMed id 12470652)9 Casana P.H....Arana M.J. (2002)
    559. Novel therapeutics for the treatment of graft-versus-host disease. (PubMed id 12225248)9 Jacobsohn D.A. (2002)
    560. KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line. (PubMed id 12635495)9 Sugimoto M....Nakaike S. (2002)
    561. An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines. (PubMed id 12271139)9 Hwang E.S....Ho I.C. (2002)
    562. Experimental autoimmune encephalomyelitis in the Wistar rat: dependence of MBP-specific T cell responsiveness on B7 costimulation. (PubMed id 12389644)9 Zhou J....Mamula M.J. (2002)
    563. Early clinical experience with a novel rapamycin deri vative. (PubMed id 11805723)9 Nashan B. (2002)
    564. [Th1-cytokines in chronic hepatitis B and C] (PubMed id 12173430)9 PriA-miagi L.S....Lisitsyna S.A. (2002)
    565. EBV associated hemophagocytic syndrome accompanied by central pontine myelinolysis. (PubMed id 12481907)9 Uehara E....Ishida T. (2002)
    566. A prospective study of inflammation markers in patients at risk of indirect acute lung injury. (PubMed id 11954822)9 Takala A....Repo H. (2002)
    567. Interleukin-2 as a therapeutic agent. (PubMed id 11837757)9 Sule N.S....Kamath S. (2001)
    568. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. (PubMed id 11527639)9 Weis M....von Scheidt W. (2001)
    569. Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapy. (PubMed id 11427636)9 van Riemsdijk-Van Overbeeke I.C....Weimar W. (2001)
    570. Deletion of the acidic-rich domain of the IL-2Rbeta chain increases receptor-associated PI3K activity. (PubMed id 11434934)9 CiprAcs A....MAcrida I. (2001)
    571. Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: evidence for in situ t-cell activation and therapeutic efficacy. (PubMed id 11146449)9 Jung G....Wilmanns W. (2001)
    572. VLDL modulates the cytokine secretion profile to a proinflammatory pattern. (PubMed id 11444855)9 Sampedro M.C....Kivatinitz S.C. (2001)
    573. Cyclodextrin modulation of T lymphocyte signal transduction with aging. (PubMed id 11470130)9 FA1lAPp T....Dupuis G. (2001)
    574. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine. (PubMed id 11523624)9 Fukasawa H....Hishida A. (2001)
    575. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. (PubMed id 11509615)9 Moon J.J. and Nelson B.H. (2001)
    576. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. (PubMed id 11120395)9 Maes M....Neveu P.J. (2001)
    577. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. (PubMed id 11689646)9 Mayne M....Jacobson S. (2001)
    578. [Antibodies and immunomodulation] (PubMed id 11577588)9 Berthoux F. (2001)
    579. [Interleukin level in endogenous depression] (PubMed id 11586704)9 Androsova L.V....Egorova M.I.u. (2001)
    580. Interleukin-2 activates human peripheral blood eosinophils. (PubMed id 11520078)9 Hoenstein R....Levi-Schaffer F. (2001)
    581. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. (PubMed id 11752512)9 Fujii T....Mimori T. (2001)
    582. Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels. (PubMed id 11324903)9 Sheiner P.A....Boros P. (2001)
    583. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. (PubMed id 11174201)9 Tanaka H....Abe S. (2001)
    584. Sanglifehrin A, a novel cyclophilin-binding immunosup pressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the c ell cycle. (PubMed id 11313401)9 Zhang L.H. and Liu J.O. (2001)
    585. New therapeutic modalities in the treatment of graft- versus-host disease. (PubMed id 11311659)9 Basara N....Fauser A.A. (2001)
    586. NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2. (PubMed id 11745353)9 Thornton S....Hirsch R. (2001)
    587. CD4+CD25high regulatory cells in human peripheral blood. (PubMed id 11466340)9 Baecher-Allan C....Hafler D.A. (2001)
    588. Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI. (PubMed id 11829320)9 Maruna P....HaluzA-k M. (2001)
    589. Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF). (PubMed id 11231439)9 Gullestad L....Aukrust P. (2001)
    590. Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101. (PubMed id 11720171)9 Shohat M....David M. (2001)
    591. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. (PubMed id 11389056)9 Descamps S....Peyrat J.P. (2001)
    592. Nutritional status impairments in HIV-infected patients are associated with increased TNF-alpha and IL-6 serum levels but not with viral load. (PubMed id 11688902)9 Galhardo M.C....Sarno E.N. (2001)
    593. Persistent inflammation and immune activation contribute to cholestasis in patients receiving home parenteral nutrition. (PubMed id 11369168)9 Reimund J.M....Baumann R. (2001)
    594. Leptin as an acute phase reactant after non-adjustable laparoscopic gastric banding. (PubMed id 11594104)9 Maruna P....Haluzik M. (2001)
    595. Synovial fluid cytokine levels in BehAset's disease. (PubMed id 11760396)9 Ertenli I....Kirazli S. (2001)
    596. Generalized Wegener's granulomatosis responding to sulfamethoxazole-trimethoprim monotherapy. (PubMed id 11506314)9 Ohtake T....Kimura M. (2001)
    597. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. (PubMed id 11740974)9 Bonaccorso S....Maes M. (2001)
    598. Anergy and human immunodeficiency virus infection. (PubMed id 11359364)9 Hegde H.R. and Robbins S.M. (2001)
    599. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. (PubMed id 11418279)9 Mikova O....Maes M. (2001)
    600. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab. (PubMed id 11683573)9 Egan C.A....Yancey K.B. (2001)
    601. IL-15 and IL-2: a matter of life and death for T cells in vivo. (PubMed id 11135625)9 Li X.C....Strom T.B. (2001)
    602. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. (PubMed id 11298119)9 Bengtsson A....Scheynius A. (2001)
    603. Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data. (PubMed id 11741345)9 Lauta V.M. (2001)
    604. [Comparative study of the functional expression of the Na/K-pump in human lymphocytes, activated by phytohemagglutinin, phorbol ester, ionomycin, and interleukin-2] (PubMed id 11347470)9 Toropova F.V....Marakhova I.I. (2001)
    605. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis. (PubMed id 11208501)9 Janiec K....Kondera-Anasz Z. (2001)
    606. Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma. (PubMed id 11244324)9 Chi K.H....Lotze M.T. (2001)
    607. Soluble immunological parameters and early prognosis of renal cell cancer patients. (PubMed id 11876546)9 Kallio J.P....Kellokumpu-Lehtinen P.L. (2001)
    608. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. (PubMed id 11174046)9 Kagaya A....Uchitomi Y. (2001)
    609. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. (PubMed id 11551026)9 Sakata N....Kawa K. (2001)
    610. Low oxygen tension and autologous plasma enhance T-cell proliferation and CD49d expression density in serum-free media. (PubMed id 11953028)9 Haddad H. and Papoutsakis E.T. (2001)
    611. Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation. (PubMed id 11112366)9 Sereti I....Lane H.C. (2000)
    612. Diagnostic value of combined evaluation of neopterin and anti-DNA antibody levels for assessment of disease activity in systemic lupus erythematosus. (PubMed id 11138331)9 Nagy G....Gergely P. (2000)
    613. Inhibition of proliferation of human peripheral blood mononuclear cells by calcium antagonists. Role of interleukin-2. (PubMed id 10791290)9 Petrov V. and Lijnen P. (2000)
    614. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. (PubMed id 10906173)9 Ahmad A....Menezes J. (2000)
    615. The role of calcineurin in lymphocyte activation. (PubMed id 10995587)9 Baksh S. and Burakoff S.J. (2000)
    616. Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. (PubMed id 10954656)9 Krueger J.G....Gottlieb A.B. (2000)
    617. Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients. (PubMed id 10689713)9 Vlk V....PospA-silovA! D. (2000)
    618. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma. (PubMed id 10906027)9 Sahid El-Radhi A....Corrigan C.J. (2000)
    619. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. (PubMed id 11134140)9 Okada H....Kanzaki H. (2000)
    620. The effect of Daclizumab in a high-risk renal transpl ant population. (PubMed id 11048998)9 Meier-Kriesche H.U....Kaplan B. (2000)
    621. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation. (PubMed id 11042520)9 Suzumiya J....Kikuchi M. (2000)
    622. Lymphocyte activation after non-thermal trauma. (PubMed id 10671932)9 Walsh D.S....Webster H.K. (2000)
    623. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. (PubMed id 10982827)9 Gu H....Neel B.G. (2000)
    624. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris. (PubMed id 10821461)9 Fiorina P....Quaini F. (2000)
    625. An early experience with Simulect (basiliximab): an I L-2 receptor antibody. (PubMed id 11119913)9 Hinduja A....Kuruvilla S. (2000)
    626. Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons. (PubMed id 10973452)9 Breen E.C....Fahey J.L. (2000)
    627. [A case of intravascular malignant lymphomatosis presenting as cerebral infarction] (PubMed id 11127588)9 Satow T....Hayashino Y. (2000)
    628. Reduced expression of systemic proinflammatory cytoki nes after off-pump versus conventional coronary artery bypass grafting. (PubMed id 11145406)9 Schulze C....Wildhirt S.M. (2000)
    629. Efficacy of Daclizumab in an African-American and His panic renal transplant population. (PubMed id 10836651)9 Meier-Kriesche H.U....Kaplan B. (2000)
    630. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. (PubMed id 10679091)9 Lord J.D....Nelson B.H. (2000)
    631. DAB(389)IL-2 (denileukin diftitox, ONTAK): a new fusion protein technology. (PubMed id 11707860)9 Foss F.M. (2000)
    632. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. (PubMed id 10620003)9 Almallah Y.Z....Eremin O. (2000)
    633. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. (PubMed id 11112905)9 Siegmund R....Herrmann D. (2000)
    634. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. (PubMed id 10705307)9 Zissel G....MA1ller-Quernheim J. (2000)
    635. Effect of parathyroid adenoma excision on interleukin-6 (IL-6) and IL-2 receptor levels. (PubMed id 10690943)9 Halabe A. and Shohat B. (2000)
    636. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. (PubMed id 11161436)9 Bruserud O. and Ulvestad E. (2000)
    637. New strategies in the treatment of graft-versus-host disease. (PubMed id 10933179)9 Basara N....Fauser A.A. (2000)
    638. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. (PubMed id 11051235)9 Grimm E.A....Buzaid A.C. (2000)
    639. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. (PubMed id 10709733)9 Raia V....Londei M. (2000)
    640. Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer. (PubMed id 10746553)9 Mantovani G....Pisano A. (2000)
    641. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. (PubMed id 10822342)9 Arolt V....Kirchner H. (2000)
    642. Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. (PubMed id 10702820)9 Moroni M....Buzio C. (2000)
    643. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, 'off-pump' technique, and conventional cardiopulmonary bypass. (PubMed id 11082370)9 Diegeler A....Mohr F.W. (2000)
    644. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation. (PubMed id 10701840)9 Schnaider T....Szamel M. (2000)
    645. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. (PubMed id 11167745)9 Fleischhack G....Bode U. (2000)
    646. [Modulation of cytokine production from human mononuclear cells by several agents] (PubMed id 11193379)9 Yoshimura T. (2000)
    647. Influence of hormone replacement therapy and aspirin on temperature regulation in postmenopausal women. (PubMed id 10956241)9 Brooks-Asplund E.M....Kenney W.L. (2000)
    648. Hormonal changes in brain death and immune activation in the donor. (PubMed id 11112013)9 Lopau K....Wanner C. (2000)
    649. Rescue of human T cells by interleukin-9 (IL-9) from IL-2 deprivation-induced apoptosis: correlation with alpha subunit expression of the IL-9 receptor. (PubMed id 10888117)9 Perdow-Hickman S. and Salgame P. (2000)
    650. Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. (PubMed id 10711641)9 Bernengo M.G....Fierro M.T. (2000)
    651. Daclizumab prevents acute rejection and improves pati ent survival post transplantation: 1 year pooled analysis. (PubMed id 10836653)9 Ekberg H....Vincenti F. (2000)
    652. Subunit structure of the high and low affinity human interleukin-15 receptors. (PubMed id 10903799)9 Lehours P....Jacques Y. (2000)
    653. Simultaneous peripubertal onset of multireactive autoimmune diseases with an unusual long-lasting remission of type 1 diabetes mellitus. (PubMed id 11106928)9 Valerio G....Pignata C. (2000)
    654. Avoidance of cyclosporine in renal transplantation: e ffects of daclizumab, mycophenolate mofetil, and steroids. (PubMed id 11004222)9 Tran H.T....Milford E.L. (2000)
    655. Development and validation of an immunoreceptor assay for simulect based on surface plasmon resonance. (PubMed id 10527499)9 Deckert F. and Legay F. (1999)
    656. [Effect of -6 degrees head-down-bed-rest on human cellular immune function] (PubMed id 11765771)9 Wen X.L....Duan Y.R. (1999)
    657. Improvement of lymphocyte proliferation in human immu nodeficiency virus infection after recombinant interleukin-2 treatment. (PubMed id 10576122)9 Afzelius P....Hansen J.E. (1999)
    658. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. (PubMed id 10504009)9 Haack M....Pollmacher T. (1999)
    659. [Unusual case of disseminated sarcoidosis with prominent gastrointestinal symptoms] (PubMed id 9987484)9 Klebl F.H....Palitzsch K.D. (1999)
    660. Reduction of acute renal allograft rejection by dacli zumab. Daclizumab Double Therapy Study Group. (PubMed id 9921806)9 Nashan B....Johnson J.R. (1999)
    661. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in BehAset's disease. (PubMed id 10651074)9 Kosar A....DA1ndar S. (1999)
    662. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. (PubMed id 10228796)9 Zaloudik J....Sheard M. (1999)
    663. IL-4 inhibits human CD8 T cell expression of the common IL-2 receptor gamma chain. (PubMed id 10224467)9 Vyas B....Kemeny D.M. (1999)
    664. Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead. (PubMed id 10413189)9 Lutz P.M....Hewett J.E. (1999)
    665. [Progressive systemic sclerosis - treatment results of extracorporeal photopheresis] (PubMed id 10501679)9 Wollina U....Vogelsang H. (1999)
    666. Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients. (PubMed id 10573061)9 Weis M....von Scheidt W. (1999)
    667. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. (PubMed id 9893120)9 Sitter T....Kooistra T. (1999)
    668. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. (PubMed id 10545303)9 Takala A....Repo H. (1999)
    669. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. (PubMed id 10202570)9 Maes M....Bosmans E. (1999)
    670. Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes. (PubMed id 10211553)9 Riesbeck K. (1999)
    671. Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients. (PubMed id 10651389)9 Wiseman L.R. and Faulds D. (1999)
    672. Signalling events mediating the activation of protein kinase C by interleukin-2 in cytotoxic T cells. (PubMed id 10372805)9 Lu Y....Durkin J.P. (1999)
    673. Cytokine profile of HIV-positive Kaposi's sarcoma derived cells in vitro. (PubMed id 10085275)9 Brockmeyer N.H....StA1rzl M. (1999)
    674. Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function. (PubMed id 10464159)9 Marmor M.D....Julius M. (1999)
    675. Suppression of atherosclerotic development in Watanabe heritable hyperlipidemic rabbits treated with an oral antiallergic drug, tranilast. (PubMed id 10027816)9 Matsumura T....Yasue H. (1999)
    676. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. (PubMed id 10540185)9 Roth-Isigkeit A....Schmucker P. (1999)
    677. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma. (PubMed id 9888464)9 Mocchegiani E....Garzetti G.G. (1999)
    678. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. (PubMed id 10358752)9 Waldmann T.A. and Tagaya Y. (1999)
    679. Modulatory effect of a serine protease inhibitor on surgical stress: its clinical implications. (PubMed id 10561733)9 Iwagaki H....Tanaka N. (1999)
    680. Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor. (PubMed id 10197798)9 Harris D.T....Pastan I. (1999)
    681. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. (PubMed id 10516077)9 Collins N.D....Lairmore M.D. (1999)
    682. Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy. (PubMed id 10449569)9 Nakahara T....Yamamoto T. (1999)
    683. Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support. (PubMed id 10417053)9 Saito S....Takaue Y. (1999)
    684. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. (PubMed id 10075926)9 Cacalano N.A....Johnston J.A. (1999)
    685. Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis. (PubMed id 10505742)9 Mangge H....Schauenstein K. (1999)
    686. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway. (PubMed id 10090941)9 Kolenko V....Finke J. (1999)
    687. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. (PubMed id 10574621)9 Bank U....Ansorge S. (1999)
    688. The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2. (PubMed id 9796831)9 Hu H.Y....vanderSpek J.C. (1998)
    689. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls. (PubMed id 9532585)9 Sivieri S....Gallo P. (1998)
    690. [The significance of cytokines in the early diagnosis of postoperative intraabdominal sepsis] (PubMed id 9658957)9 GA1rlich R....CermA!k J. (1998)
    691. Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth. (PubMed id 9629279)9 Arzt E....Stalla G.K. (1998)
    692. Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection. (PubMed id 9831196)9 David D....Theze J. (1998)
    693. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus] (PubMed id 9511265)9 Scudla V....HermanovA! Z. (1998)
    694. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. (PubMed id 9432986)9 Schulz O....Shakib F. (1998)
    695. Molecular characterization of the signal responsible for the targeting of the interleukin 2 receptor beta chain toward intracellular degradation. (PubMed id 9792646)9 Subtil A....Dautry-Varsat A. (1998)
    696. Serum cytokine levels after HLA-identical bone marrow transplantation. (PubMed id 9798695)9 Liem L.M....Goulmy E. (1998)
    697. Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. (PubMed id 9546432)9 Suminami Y....Whiteside T.L. (1998)
    698. Functional and physical association of a cell surface phospholipid and interleukin-2 receptor p55(alpha) subunits. (PubMed id 9804890)9 Saragovi H.U....ThAcze J. (1998)
    699. Immune response and cytokines in septic rats undergoing blood transfusion. (PubMed id 9878327)9 Salinas J.C....Lozano R. (1998)
    700. Molecular cloning and expression of feline interleukin-16. (PubMed id 9773277)9 Leutenegger C.M....Lutz H. (1998)
    701. Cytokine gene expression in normal human lymphocytes in response to stimulation. (PubMed id 9605988)9 Fan J....Fahey J.L. (1998)
    702. Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients. (PubMed id 11061586)9 Lissoni P....MandalA M. (1998)
    703. Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis. (PubMed id 9714363)9 Pountain G....Cawston T.E. (1998)
    704. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. (PubMed id 9423851)9 Vazquez N....Lyman C.A. (1998)
    705. The Hsp90-specific inhibitor, geldanamycin, blocks CD 28-mediated activation of human T lymphocytes. (PubMed id 9747895)9 Schnaider T....Szamel M. (1998)
    706. DAB389IL2 diphtheria fusion toxin produces clinical r esponses in tumor stage cutaneous T cell lymphoma. (PubMed id 9590158)9 Duvic M....Frankel A.E. (1998)
    707. Interleukin-15 and its role in chronic inflammatory diseases. (PubMed id 9719492)9 Kirman I....Nielsen O.H. (1998)
    708. Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease. (PubMed id 9472806)9 Rumi C....Leone G. (1998)
    709. [Expression of IL-2 receptor in peripheral blood lymphocytes and bronchoalveolar lavage fluid (BAL) in patients with sarcoidosis] (PubMed id 9686498)9 Koktysz M....RoliA8ski J. (1998)
    710. Cells and cytokines in pollinosis. (PubMed id 9823418)9 Carlos A.G....Melo A. (1998)
    711. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. (PubMed id 9600494)9 Chan M.T....Spahn J.D. (1998)
    712. Biological agents in rheumatoid arthritis: which ones could be used in combination? (PubMed id 18020567)9 Lorenz M. and Kalden J.R. (1998)
    713. Increased eosinophil activity in acute Plasmodium falciparum infection--association with cerebral malaria. (PubMed id 9649195)9 Kurtzhals J.A....Hviid L. (1998)
    714. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. (PubMed id 9525643)9 Trueblood E.S....McElwain T.F. (1998)
    715. Is malnutrition overdiagnosed in older hospitalized patients? Association between the soluble interleukin-2 receptor and serum markers of malnutrition. (PubMed id 9520912)9 Rosenthal A.J....Adler R.A. (1998)
    716. Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. (PubMed id 9916886)9 Miller A....Lahat N. (1998)
    717. Perioperative cytokine release during coronary artery bypass grafting in patients of different ages. (PubMed id 9764599)9 Roth-Isigkeit A....Seyfarth M. (1998)
    718. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. (PubMed id 9855088)9 Messmann H....SchAPlmerich J. (1998)
    719. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid. (PubMed id 9459128)9 Inaoki M. and Takehara K. (1998)
    720. Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. (PubMed id 9875675)9 Zoll B....Schmidt-Wolf I.G. (1998)
    721. Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling. (PubMed id 9802969)9 Haughn L....Julius M. (1998)
    722. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides. (PubMed id 9674399)9 Saleh M.N....Nichols J.C. (1998)
    723. The use of antibodies against the IL-2 receptor in tr ansplantation. (PubMed id 9794841)9 Waldmann T.A. and O'Shea J. (1998)
    724. Effects of chromium extract on cytokine release by mononuclear cells. (PubMed id 9678877)9 Granchi D....Pizzoferrato A. (1998)
    725. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions. (PubMed id 9591046)9 Sikora J....Zeromski J. (1998)
    726. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. (PubMed id 9834071)9 Soares M.V....Akbar A.N. (1998)
    727. Human hematopoietic cell express two forms of the cytokine receptor common gamma-chain (gamma c). (PubMed id 9444398)9 Shi Y.F....Mills G.B. (1997)
    728. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. (PubMed id 9201264)9 Allavena P....Mantovani A. (1997)
    729. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. (PubMed id 9815731)9 Fujimiya Y....Ebina T. (1997)
    730. Growth factor receptors: structure, mechanism, and drug discovery. (PubMed id 9566117)9 McInnes C. and Sykes B.D. (1997)
    731. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. (PubMed id 9300731)9 Kolenko V....Finke J. (1997)
    732. Expression of cytokine receptors on follicular dendritic cells. (PubMed id 9389700)9 Yamada K....Tsukamoto M. (1997)
    733. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin. (PubMed id 9237106)9 Valentine J.E. and Sewell W.A. (1997)
    734. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. (PubMed id 9195507)9 Russell A.S....Maksymowych W.P. (1997)
    735. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines. (PubMed id 9180137)9 Mantovani G....Del Giacco G.S. (1997)
    736. Interactions of the Alzheimer beta amyloid fragment (25-35) with peripheral blood dendritic cells. (PubMed id 9147374)9 Schmitt T.L....Grubeck-Loebenstein B. (1997)
    737. Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501. (PubMed id 9180296)9 Weidmann E....Bergmann L. (1997)
    738. A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID). (PubMed id 9367398)9 Rump J.A....Peter H.H. (1997)
    739. A second determinant of binding to the p75 neurotroph in receptor revealed by alanine-scanning mutagenesis of a conserved loop in ner ve growth factor. (PubMed id 9407092)9 RydAcn M. and IbA!A+ez C.F. (1997)
    740. Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea. (PubMed id 9163352)9 Hsu H.C....Lin J.Y. (1997)
    741. Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection. (PubMed id 9191882)9 Salazar-Gonzalez J.F....Fahey J.L. (1997)
    742. Regulation of IL-2 signaling. (PubMed id 9209410)9 Higuchi M....Sugamura K. (1997)
    743. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. (PubMed id 9328122)9 Kakumu S....Yoshika Y. (1997)
    744. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation. (PubMed id 9135549)9 Nachbaur D....Niederwieser D. (1997)
    745. Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. (PubMed id 9413852)9 Sablotzki A....Hempelmann G. (1997)
    746. [Prevention and treatment of seasonal asthmatic patients by combined invigorating kidney for preventing asthma tablets and beclomethasone dipropinate] (PubMed id 10322818)9 Xu D. and Xu R.H. (1997)
    747. In vivo immunomodulatory effects of clozapine in schizophrenia. (PubMed id 9323354)9 Maes M....Meltzer H.Y. (1997)
    748. Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells. (PubMed id 9130512)9 Ballow M....Rich G. (1997)
    749. Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals. (PubMed id 9863500)9 Achour A....Zagury D. (1997)
    750. A high serum concentration of interleukin-6 is predic tive of relapse in quiescent Crohn's disease. (PubMed id 9391781)9 Louis E....Mary J.Y. (1997)
    751. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. (PubMed id 9401080)9 Murase T....Saito H. (1997)
    752. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. (PubMed id 9242543)9 Agostini C....Semenzato G. (1997)
    753. Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. (PubMed id 9414637)9 Bruserud O....Nesthus I. (1997)
    754. IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506. (PubMed id 9103428)9 Mori A....Okudaira H. (1997)
    755. A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: increased level of soluble IL-2R and reduced protein tyrosine phosphorylation. (PubMed id 9326745)9 Ashkenazi E....Brodie C. (1997)
    756. Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis. (PubMed id 9462277)9 al-Attas R.A....Ahmed el-FE . (1997)
    757. Microtubule depolymerization inhibits clathrin coated-pit internalization in non-adherent cell lines while interleukin 2 endocytosis is not affected. (PubMed id 9410882)9 Subtil A. and Dautry-Varsat A. (1997)
    758. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. (PubMed id 8977222)9 Guex-Crosier Y....Roberge F.G. (1997)
    759. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. (PubMed id 9326248)9 Badolato R....Musso T. (1997)
    760. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma. (PubMed id 9180138)9 Lollini P.L....Nanni P. (1997)
    761. Interleukin 2 induces a transient downregulation of protein phosphatase 1 and 2A activity in human T cells. (PubMed id 9098929)9 Brockdorff J....Odum N. (1997)
    762. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. (PubMed id 8978293)9 Zambello R....Semenzato G. (1997)
    763. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma. (PubMed id 9260602)9 Boyano M.D....DA-az-PAcrez J.L. (1997)
    764. Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. (PubMed id 9396961)9 Pollmacher T....Mullington J. (1997)
    765. Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variations. (PubMed id 9479598)9 Lissoni P....Fumagalli L. (1997)
    766. Flow cytometric analysis of lymphocytes in cerebrospinal fluid in patients with tick-borne encephalitis. (PubMed id 9048982)9 Tomazic J. and Ihan A. (1997)
    767. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? (PubMed id 9042815)9 Dalekos G.N....Siamopoulos K.C. (1997)
    768. An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitro. (PubMed id 9226474)9 Rayward J....Alvarez-Mon M. (1997)
    769. [Cellular immunity in childhood iron deficiency anemia with recurrent respiratory infections] (PubMed id 15625892)9 Liu W....Guo C. (1997)
    770. Selective expression of the interleukin-2 gene discriminates between the auto- and allo-mixed lymphocyte reaction. (PubMed id 9106332)9 Moudgil A....Jordan S.C. (1997)
    771. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. (PubMed id 9192665)9 Chen M....O'Shea J.J. (1997)
    772. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. (PubMed id 9028322)9 Ross M.E. and Caligiuri M.A. (1997)
    773. IL-6 is a survival prognostic factor in renal cell carcinoma. (PubMed id 9271323)9 Thiounn N....DebrAc B. (1997)
    774. Host defensive, immunological, and microbiological observations of an early-onset periodontitis patient with virus-associated hemophagocytic syndrome. (PubMed id 9444599)9 Kono T....Murayama Y. (1997)
    775. [Liver transplantation and splenectomy in idiopathic portal hypertension] (PubMed id 9265393)9 Petrowsky H....Markus B.H. (1997)
    776. Interleukin-15 protects from lethal apoptosis in vivo. (PubMed id 9334724)9 Bulfone-Paus S....Kunzendorf U. (1997)
    777. Clinical value of cytokine antagonists in infectious complications. (PubMed id 9178365)9 Iwagaki H....Tanaka N. (1997)
    778. Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. (PubMed id 9181459)9 Davis-Daneshfar A....Dummer R. (1997)
    779. Modeling the proliferative response of T cells to IL-2 and IL-4. (PubMed id 9184697)9 Burke M.A....Morel P.A. (1997)
    780. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. (PubMed id 8599886)9 Biglino A....Gioannini P. (1996)
    781. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. (PubMed id 8624802)9 Wang H.Y....Keegan A.D. (1996)
    782. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. (PubMed id 8863007)9 Wilke I....Kirchner H. (1996)
    783. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. (PubMed id 8933279)9 Martin S....Kolb H. (1996)
    784. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. (PubMed id 8921963)9 Salvucci O....Chouaib S. (1996)
    785. Expression of IL-2 receptor beta-chain in B16 melanoma cells. (PubMed id 9087807)9 Garcia De Galdeano A....CaA+avate M.L. (1996)
    786. Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. (PubMed id 8757332)9 Elloso M.M....Weidanz W.P. (1996)
    787. Structure of the fab fragment of SDZ CHI621: a chimer ic antibody against CD25. (PubMed id 15299676)9 Mikol V. (1996)
    788. Interactions of tunicate immunomodulatory proteins with mammalian cells. (PubMed id 8934650)9 Raftos D. (1996)
    789. Prognostic significance of immunological evaluation in colorectal cancer. (PubMed id 10851496)9 Berghella A.M....Casciani C.U. (1996)
    790. Peripheral T cell activation in long-term renal transplant patients: concordant upregulation of adhesion molecules and cytokine gene transcription. (PubMed id 8959642)9 Kern F....Reinke P. (1996)
    791. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer. (PubMed id 10851498)9 Contasta I....Casciani C.U. (1996)
    792. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. (PubMed id 8631883)9 Lin J.-X.... Leonard W.J. (1996)
    793. Immunomodulatory action of levofloxacin on cytokine p roduction by human peripheral blood mononuclear cells. (PubMed id 8957581)9 Yoshimura T....Nagai H. (1996)
    794. Analysis of monoclonal antibodies reactive with molecules upregulated or expressed only on activated lymphocytes. (PubMed id 8896219)9 Davis W.C....Bohach G.A. (1996)
    795. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. (PubMed id 8878397)9 Woodward J.E....Baliga P. (1996)
    796. Cell culture observations of human postnatal thymic epithelium: an in vitro model for growth and humoral influence on intrathymic T lymphocyte maturation. (PubMed id 8899432)9 Bodey B....Kaiser H.E. (1996)
    797. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. (PubMed id 8919323)9 Maes M....Meltzer H.Y. (1996)
    798. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. (PubMed id 8639878)9 MrA^zek E....Caligiuri M.A. (1996)
    799. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. (PubMed id 8721989)9 Ferrag F....Kelly P.A. (1996)
    800. T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient. (PubMed id 8781427)9 Morelon Saint Basile G. (1996)
    801. Cytokines in BehAset's disease. (PubMed id 8882039)9 Sayinalp N....Kirazli S. (1996)
    802. Role of prolactin in the modulation of NK and LAK cel l activity after short- or long-term morphine administration in neoplastic pati ents. (PubMed id 9080251)9 Provinciali M....Fabris N. (1996)
    803. Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer. (PubMed id 8708712)9 Gause B.L....Longo D.L. (1996)
    804. Immune system of cold-exposed and cold-adapted humans. (PubMed id 8925815)9 JanskA1 L....KamA-nkovA! J. (1996)
    805. IL-4 down-regulates the responsiveness of human intraepithelial lymphocytes. (PubMed id 8809149)9 Ebert E.C. and Roberts A.I. (1996)
    806. An upregulation of interleukin-2 receptor, transferrin receptor expression and cytokine production mediated by hemin in human peripheral blood mononuclear cells. (PubMed id 8776616)9 Tsuji A....Nakamura H. (1996)
    807. Immunological studies of herpes simplex virus infection in children with atopic eczema. (PubMed id 8745891)9 Goodyear H.M....Harper J.I. (1996)
    808. Interleukin-15 gene expression in human astrocytes and microglia in culture. (PubMed id 8804052)9 Lee Y.B....Kim S.U. (1996)
    809. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene. (PubMed id 8605323)9 Taylor N....Weinberg K. (1996)
    810. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA). (PubMed id 9020407)9 Fagiolo E. and Abenante L. (1996)
    811. Serum cytokine and anti-Fc gamma R autoantibody measurements in patients with systemic sclerosis. (PubMed id 8721484)9 Szegedi A....Boros P. (1996)
    812. Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. (PubMed id 8855979)9 Tsunoda T....Arii K. (1996)
    813. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease. (PubMed id 8750571)9 Aust G....Heberling H.J. (1996)
    814. Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. (PubMed id 8874750)9 Rajan G.P....Dummer R. (1996)
    815. Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease. (PubMed id 8993754)9 Gottlieb A.A....Kern C.H. (1996)
    816. Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex. (PubMed id 8568232)9 de Jong J.L....Sondel P.M. (1996)
    817. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. (PubMed id 8734356)9 Kennedy M.K. and Park L.S. (1996)
    818. IL-2 receptor gamma chain expression on CD34 positive hematopoietic progenitor cells from bone marrow and cord blood. (PubMed id 8804156)9 Itano M....Konno T. (1996)
    819. Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biologic effects. (PubMed id 8877734)9 Witt P.L....Borden E.C. (1996)
    820. Age-related tyrosine-specific protein phosphorylation defect in human T lymphocytes activated through CD3, CD4, CD8 or the IL-2 receptor. (PubMed id 8819096)9 Quadri R.A....Proust J.J. (1996)
    821. Immune and nutritional effects of early enteral nutrition after major abdominal operations. (PubMed id 8639722)9 Braga M....Carlo V.D. (1996)
    822. Early calcium signaling and calcium requirements for the IL-2 receptor expression and IL-2 production in stimulated lymphocytes. (PubMed id 8912879)9 Komada H....Izutsu K. (1996)
    823. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. (PubMed id 8890166)9 Tagaya Y....Waldmann T.A. (1996)
    824. The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. (PubMed id 8552611)9 Lai S.Y....Goldsmith M.A. (1996)
    825. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. (PubMed id 8698387)9 Strickland D....Holt P.G. (1996)
    826. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. (PubMed id 8647198)9 Kumaki S....Cosman D. (1996)
    827. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. (PubMed id 8691130)9 Welborn M.B....Moldawer L.L. (1996)
    828. [Changes of humoral and cellular immunity in schizophrenia] (PubMed id 8984518)9 Wojtanowska M. and Rybakowski J. (1996)
    829. Chromosomal assignment and genomic structure of Il15. (PubMed id 7759105)9 Anderson D.M....Morris S.W. (1995)
    830. Modulation of postoperative immune response by entera l nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. (PubMed id 7539633)9 Senkal M....Zumtobel V. (1995)
    831. Induction of responsiveness in superantigen-induced a nergic T cells. Role of ligand density and costimulatory signals. (PubMed id 7602125)9 Heeg K. and Wagner H. (1995)
    832. Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma. (PubMed id 7621064)9 Fukuda T....Makino S. (1995)
    833. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. (PubMed id 7777534)9 Fujii H....Miyazaki T. (1995)
    834. IL2-ricin fusion toxin is selectively cytotoxic in vi tro to IL2 receptor-bearing tumor cells. (PubMed id 8608178)9 Frankel A....Willingham M. (1995)
    835. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. (PubMed id 7559633)9 Lai K.S.... Liu E.T. (1995)
    836. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. (PubMed id 7546418)9 Jacobson M.A....Collier A.C. (1995)
    837. Stimulus-dependent production of cytokines and pterins by peripheral blood mononuclear cells. (PubMed id 7622184)9 Henderson D.C. and Rippin J.J. (1995)
    838. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. (PubMed id 7594483)9 Lin W.C....Whiteside T.L. (1995)
    839. Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. (PubMed id 7624740)9 Saatvedt K....Mollnes T.E. (1995)
    840. Effects of 'systemic' budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. (PubMed id 7573828)9 Oddera S....Rossi G.A. (1995)
    841. Evaluation by histology, immunohistology and PCR of p rotocollized renal biopsies 1 week post-transplant in relation to subsequent re jection episodes. (PubMed id 7566615)9 Kooijmans-Coutinho M.F....van der Woude F.J. (1995)
    842. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. (PubMed id 7772617)9 Maes M....Bosmans E. (1995)
    843. Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative. (PubMed id 8655287)9 Shannon E.J. and Sandoval F. (1995)
    844. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. (PubMed id 8788239)9 Born J....Fehm H.L. (1995)
    845. [Determination of cytokines and cytokine receptors in premature labor] (PubMed id 7498714)9 Hampl M....Gallati H. (1995)
    846. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. (PubMed id 8866788)9 Lin J....Bromberg J.S. (1995)
    847. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. (PubMed id 7535338)9 Musso T....McVicar D.W. (1995)
    848. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. (PubMed id 7561680)9 Seder R.A....McDyer J.F. (1995)
    849. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. (PubMed id 7759480)9 Xu X....Chong A.S. (1995)
    850. Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently. (PubMed id 7632950)9 Kumaki S....Cosman D. (1995)
    851. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU. (PubMed id 8572636)9 De Brabander M....Vogels O. (1995)
    852. Primary cutaneous CD30(Ki-1)-positive lymphoma of non-T, non-B origin. (PubMed id 7599389)9 Akiyama C....Tamaki K. (1995)
    853. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome. (PubMed id 7633846)9 Qazilbash M.H....Liu J.M. (1995)
    854. Cytokine gene expression after allogeneic bone marrow transplantation. (PubMed id 7787751)9 Tanaka J....Miyazaki T. (1995)
    855. Thiols decrease human interleukin (IL) 4 production a nd IL-4-induced immunoglobulin synthesis. (PubMed id 7500023)9 Jeannin P....Bonnefoy J.Y. (1995)
    856. Selection of monoclonal antibodies for the identification of lymphocyte surface antigens in the New World primate Saguinus oedipus oedipus (cotton top tamarin). (PubMed id 7836781)9 Wilson A.D....Morgan A.J. (1995)
    857. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus. (PubMed id 7586731)9 Combates N.J....Raska K. (1995)
    858. Ouabain induces inhibition of the progression phase in human T-cell proliferation. (PubMed id 7593202)9 Brodie C....Gelfand E.W. (1995)
    859. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. (PubMed id 7697531)9 Hornef M.W....Kirchner H. (1995)
    860. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC. (PubMed id 8528743)9 Mantovani G....Santona M.C. (1995)
    861. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. (PubMed id 7545429)9 GorschlA1ter M....Tesch H. (1995)
    862. Pentoxifylline exerts synergistic immunomodulatory ef fects in combination with dexamethasone or cyclosporin A. (PubMed id 8964650)9 Funk J.O....Zabel P. (1995)
    863. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma. (PubMed id 7859883)9 Stasi R....Cantonetti M. (1995)
    864. Molecular analysis of Ras activation by tyrosine phosphorylated Vav. (PubMed id 8554611)9 Gulbins E....Coggeshall K.M. (1995)
    865. delta 9-Tetrahydrocannabinol (THC) causes the variabl e expression of IL2 receptor subunits. (PubMed id 7636714)9 Zhu W....Klein T.W. (1995)
    866. Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2. (PubMed id 7844609)9 Triozzi P.L....Villasmil P.M. (1995)
    867. Cytokines and adhesion molecules in respiratory allergy. (PubMed id 7626191)9 Palma-Carlos A.G....Melo A. (1995)
    868. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis. (PubMed id 7677440)9 Salvarani C....Portioli I. (1995)
    869. Angiocentric immunoproliferative lesions of the skin show lobular panniculitis and are mainly disorders of large granular lymphocytes. (PubMed id 8522304)9 Takeshita M....Uike N. (1995)
    870. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. (PubMed id 7848311)9 Mangge H....Schauenstein K. (1995)
    871. [Cytokine mediators in acute inflammation and chronic course of viral hepatitis] (PubMed id 7727201)9 Missale G....Fiaccadori F. (1995)
    872. HLA-DR expression on CD8 lymphocytes from gastric mucosa in urease-positive and urease-negative gastritis. (PubMed id 7773247)9 Ihan A....Gubina M. (1995)
    873. Interleukin-10 downregulates proliferation and expression of interleukin-2 receptor p55 chain and interferon-gamma, but not interleukin-2 or interleukin-4, by parasite-specific helper T cell clones obtained from cattle chronically infected with Babesia bovis or Fasciola hepatica. (PubMed id 8564714)9 Chitko-McKown C.G....Brown W.C. (1995)
    874. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID. (PubMed id 8750273)9 Minegishi Y....Yata J. (1995)
    875. Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosa. (PubMed id 7794541)9 Snijders F....Reiss P. (1995)
    876. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. (PubMed id 7576120)9 Sabahi F....Frenkel L.D. (1995)
    877. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. (PubMed id 7727142)9 Deng M.C....Scheld H.H. (1995)
    878. Lack of proliferative response by gluten-specific T cells in the blood and gut of patients with dermatitis herpetiformis. (PubMed id 7492350)9 Baker B.S....Fry L. (1995)
    879. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. (PubMed id 7540639)9 Toba K....Shibata A. (1995)
    880. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein. (PubMed id 8580481)9 Zhang M....Lu S. (1995)
    881. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. (PubMed id 7797904)9 von der MAPhlen M.A....Bauer R. (1995)
    882. [Eosinophil colony stimulating factor (Eo-CSF) activity and soluble interleukin-2 receptor (sIL-2R) in patients with reactive eosinophilia] (PubMed id 8857112)9 Watanabe K....Furusawa S. (1995)
    883. Oligoclonal activation of CD4+ T lymphocytes in poste rior uveitis. (PubMed id 7882564)9 Feron E.J....Lightman S.L. (1995)
    884. Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants. (PubMed id 8574169)9 Tanaka J....Sakurada K. (1995)
    885. Acute renal and immunological effects of low-dose cyclosporin in humans. (PubMed id 8559498)9 De Nicola L....Conte G. (1995)
    886. p75 and Trk: a two-receptor system. (PubMed id 7571013)9 Chao M.V. and Hempstead B.L. (1995)
    887. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. (PubMed id 7486666)9 Taniguchi T....Liu Z.J. (1995)
    888. Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. (PubMed id 7718508)9 Kimura Y....Sugamura K. (1995)
    889. Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma. (PubMed id 7819101)9 Stasi R....Tura S. (1994)
    890. PHA induces IL-2 receptors on B-CLL cells and is a potential biological response modifier for the LIL-2-diphtheria toxin, DAB486IL-2. (PubMed id 8107488)9 Bulger K....McCaffrey R. (1994)
    891. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. (PubMed id 8070818)9 Leonard W.J....McBride O.W. (1994)
    892. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. (PubMed id 8298124)9 Voss S.D....Sondel P.M. (1994)
    893. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sezary syndrome. (PubMed id 8113839)9 Foss F.M....Sausville E.A. (1994)
    894. Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. (PubMed id 7850074)9 Takeshita M....Goto H. (1994)
    895. SH2-dependent association of phosphatidylinositol 3'-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain. (PubMed id 7509794)9 Truitt K.E....Imboden J.B. (1994)
    896. An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2. (PubMed id 7852053)9 Courtney L.P....Karavodin L.M. (1994)
    897. [Cytokine and disease] (PubMed id 7523745)9 Tsudo M. (1994)
    898. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients. (PubMed id 7911453)9 Shingu M....Naono T. (1994)
    899. Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. (PubMed id 8191883)9 Gallo P....Tavolato B. (1994)
    900. [Cytokines and vasculitis] (PubMed id 7933578)9 Shingu M. and Nobunaga M. (1994)
    901. The interplay of interleukin-10 (IL-10) and interleukin-2 (IL-2) in humoral immune responses: IL-10 synergizes with IL-2 to enhance responses of human B lymphocytes in a mechanism which is different from upregulation of CD25 expression. (PubMed id 8069928)9 Itoh K....Hirohata S. (1994)
    902. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure. (PubMed id 8082082)9 Stasi R....Papa G. (1994)
    903. Comparison of salmeterol with placebo in mild asthma: effect on peripheral blood phagocyte function and cytokine levels. (PubMed id 7920018)9 Ramage L....Dhillon D.P. (1994)
    904. Primary activation of V gamma 9-expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by IL-10. (PubMed id 7909828)9 Pechhold K....Kabelitz D. (1994)
    905. A similar expression pattern of adhesion molecules between intermediate TCR cells in the liver and intraepithelial lymphocytes in the intestine. (PubMed id 7799843)9 Ohtsuka K....Abo T. (1994)
    906. The effect of azathioprine on serum levels of interleukin 6 and soluble interleukin 2 receptor. (PubMed id 8165444)9 Crilly A....Madhok R. (1994)
    907. Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency. (PubMed id 7829103)9 Deschenes S.M....Henthorn P.S. (1994)
    908. Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells. (PubMed id 8186198)9 Holter W....Knapp W. (1994)
    909. SjAPgren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. (PubMed id 8056525)9 Jones D.T....Pflugfelder S.C. (1994)
    910. Adoptive immunotherapy with activated peripheral blood lymphocytes. (PubMed id 8152278)9 Horvath J. and Sinkovics J.G. (1994)
    911. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73. (PubMed id 8027539)9 Resta R....Thompson L.F. (1994)
    912. Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression. (PubMed id 8169977)9 Cignetti A....Foa R. (1994)
    913. Differential expression and regulation of cytokine mRNAs in normal human CD45R T cell subsets. (PubMed id 7518260)9 Beckman I....Bradley J. (1994)
    914. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. (PubMed id 8077727)9 Aurelius E....StrannegAYrd O. (1994)
    915. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. (PubMed id 7957562)9 Joyce D.A....Brennan F.M. (1994)
    916. Relationship of IgG glycosylation, soluble IL-2 receptors and IL-6 to disease activity in rheumatoid arthritis. (PubMed id 7921769)9 Bond A....Hay F.C. (1994)
    917. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. (PubMed id 8168046)9 Raziuddin M. (1994)
    918. Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjogren's syndrome. (PubMed id 8082485)9 Aziz K.E....Wakefield D. (1994)
    919. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). (PubMed id 7962625)9 Ramshaw A.L....Parums D.V. (1994)
    920. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. (PubMed id 8148443)9 Patarca R....Fletcher M.A. (1994)
    921. p56lck phosphorylation by Ca2+/calmodulin-dependent protein kinase type II. (PubMed id 8292050)9 Bland M.M....Carrera A.C. (1994)
    922. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. (PubMed id 7699643)9 Madson K.L....Osborn T.G. (1994)
    923. Activation via TCR or IL-2 receptor of a CD8+ suppressor T cell clone: effect on IL-10 production and on proliferation of the suppressor T cell. (PubMed id 7765241)9 Minai Y....Kaminogawa S. (1994)
    924. Expression of alpha-fetoprotein and interleukin 2 receptors and impairment of membrane fluidity in peripheral blood mononuclear cells from AIDS and related syndromes. (PubMed id 7529036)9 Macho A....Uriel J. (1994)
    925. Coiled-coil molecular recognition: directed solution assembly of receptor ectodomains. (PubMed id 7831285)9 Wu Z....Ciardelli T.L. (1994)
    926. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/lymphoma in the early stages of the disease. (PubMed id 8176252)9 Oishi M....Honda M. (1994)
    927. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. (PubMed id 7519240)9 Clement M.V. and Stamenkovic I. (1994)
    928. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. (PubMed id 7532933)9 Morikawa K....Iwamoto K. (1994)
    929. T lymphocytes bearing the gamma/delta T-cell receptor in cutaneous lesions of dermatitis herpetiformis. (PubMed id 7868753)9 Kell D.L....Smoller B.R. (1994)
    930. Peripheral blood hairy cell leukemia cells express only low affinity IL-2 receptors. (PubMed id 8107487)9 Bulger K....McCaffrey R. (1994)
    931. Response of soluble IL-2 receptor levels during gold therapy for rheumatoid arthritis. (PubMed id 8039284)9 Sheldon A....Roberts-Thomson P.J. (1994)
    932. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. (PubMed id 7981154)9 Ishii N....Sugamura K. (1994)
    933. [The effect of interleukin-2, interleukin-4 and tumor necrosis factor on LAK cells activity] (PubMed id 7922766)9 Zeng Z....Yu M. (1994)
    934. CD3- and CD28-activating pathways in HCV infection. (PubMed id 7986335)9 Corado J.A....Machado I.V. (1994)
    935. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin. (PubMed id 7806419)9 Gardinali M....Zoni U. (1994)
    936. Tissue-specific regulation of IL-4 mRNA expression in human tonsil. (PubMed id 7507959)9 Secrist H....Peters M.G. (1994)
    937. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule. (PubMed id 7909498)9 Gerli R....Bertotto A. (1994)
    938. Delta-9-tetrahydrocannabinol treatment results in a s uppression of interleukin-2-induced cellular activities in human and murine lym phocytes. (PubMed id 7523319)9 Trisler K. and Specter S. (1994)
    939. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. (PubMed id 8206753)9 Batuman O.A....Pomerantz R.J. (1994)
    940. Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma. (PubMed id 8035405)9 Puett D.W. and Fuchs H.A. (1994)
    941. In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. (PubMed id 8198981)9 Deehan D.J....Eremin O. (1994)
    942. IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. (PubMed id 7829104)9 Henthorn P.S....Felsburg P.J. (1994)
    943. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes. (PubMed id 8039243)9 Bryan R.G....Rich R.R. (1994)
    944. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. (PubMed id 8084452)9 Cristol J.P....Mion C. (1994)
    945. Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2. (PubMed id 7521509)9 Hu Z.L....Katsuki T. (1994)
    946. Peripheral blood reduction of memory (CD29+, CD45RO+, and 'bright' CD2+ and LFA-1+) T lymphocytes in Papillon-Lefevre syndrome. (PubMed id 7532641)9 Gongora R....Arnaiz-Villena A. (1994)
    947. [Functional roles of LFA-1 involved in signal transduction for thymocyte activation] (PubMed id 7879572)9 Lu L.S. and Chen W.F. (1994)
    948. Genistein, a tyrosine kinase inhibitor, decreased the affinity of p56lck to beta-chain of interleukin-2 receptor in human natural killer (NK)-rich cells and decreased NK-mediated cytotoxicity. (PubMed id 7938054)9 Nishio K....Saijo N. (1994)
    949. The membrane proximal segment of the IL-2 receptor beta-chain acidic region is essential for IL2-dependent protein tyrosine kinase activation. (PubMed id 8152289)9 Williamson P....Gaulton G. (1994)
    950. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. (PubMed id 8197161)9 Bamford R.N....Waldmann T.A. (1994)
    951. Study of IL-2 receptor expression after chemoimmunotherapy in patients treated for metastatic malignant melanoma. (PubMed id 8082289)9 Mouawad R....Soubrane C. (1994)
    952. Immunologic parameters in systemic sclerosis. (PubMed id 8112935)9 Bruns M....Haustein U.F. (1994)
    953. The effects of the dialysis membrane on cytokine release. (PubMed id 8011981)9 Zaoui P. and Hakim R.M. (1994)
    954. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. (PubMed id 8178864)9 Lencki S.G....Eglinton G.S. (1994)
    955. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. (PubMed id 7523571)9 Carson W.E....Caligiuri M.A. (1994)
    956. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities? (PubMed id 7839469)9 Guida M....De Lena M. (1994)
    957. Lymphokine receptors: a target for immunotherapy of l ymphomas. (PubMed id 8172810)9 Waldmann T.A. (1994)
    958. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors. (PubMed id 7976492)9 Lissoni P....Angelini A. (1994)
    959. Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites. (PubMed id 7736535)9 Mantovani G....Del Giacco G.S. (1994)
    960. [Immunologic parameters in women with normal pregnancy and pre-eclampsia] (PubMed id 8023619)9 Bettin S....Jahn S. (1994)
    961. Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine. (PubMed id 7923243)9 Berd D....Murphy G. (1994)
    962. Expression of the IL2 receptor alpha, beta and gamma chains in hairy cell leukemia. (PubMed id 7820050)9 de Totero D....Foa R. (1994)
    963. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. (PubMed id 8178155)9 Grabstein K.H.... Giri J.G. (1994)
    964. Does IL-2 receptor expression and secretion in chronic B-cell leukemia have a role in down-regulation of the immune system? (PubMed id 8289505)9 Burton J. and Kay N.E. (1994)
    965. Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy. (PubMed id 8306497)9 Soubrane C....Khayat D. (1994)
    966. Preferential utilization of the immature JH segment and absence of somatic mutation in the CDR3 junction of the Ig H chain gene in three X-linked severe combined immunodeficiency patients. (PubMed id 7865464)9 Minegishi Y....Yata J. (1994)
    967. Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis. (PubMed id 7842530)9 Luqmani R....Emery P. (1994)
    968. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. (PubMed id 8364205)9 Desreumaux P....Prin L. (1993)
    969. Interleukin-4 bypass of the immunosuppressive effect mediated by interleukin-2 receptor antibodies. (PubMed id 8434232)9 Steinmann J....MA1ller-Ruchholtz W. (1993)
    970. Restricted cytokine expression in rheumatoid arthritis. (PubMed id 8318038)9 Chen E....Fish E.N. (1993)
    971. Expression of IL-2 receptors in human melanoma cells. (PubMed id 8317884)9 Rimoldi D....Carrel S. (1993)
    972. Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens. (PubMed id 8370177)9 Panzer S....Matsuki K. (1993)
    973. Increase of interleukin 2 receptor and CD45RO antigen on lymphocytes cultured with human cytomegalovirus. (PubMed id 8384933)9 Nakano T....Sakurai M. (1993)
    974. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. (PubMed id 8443757)9 Lissoni P....Biondi A. (1993)
    975. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. (PubMed id 8093434)9 Quiding M....Czerkinsky C. (1993)
    976. Pivotal role of endogenous TNF-alpha in the IL-2-driven activation and proliferation of the functionally immature NK free subset. (PubMed id 8402935)9 Jewett A. and Bonavida B. (1993)
    977. Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. (PubMed id 8093435)9 Chopra R.K....Margolick J.B. (1993)
    978. Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression. (PubMed id 7678210)9 Becker J.C....BrAPcker E.B. (1993)
    979. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. (PubMed id 8419408)9 Terada N....Gelfand E.W. (1993)
    980. Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus. (PubMed id 8358979)9 Sawada S....Mitamura K. (1993)
    981. [Effect of arginine supplementation on T-lymphocyte function in burn patients] (PubMed id 8143212)9 Lu S.L. (1993)
    982. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. (PubMed id 8099861)9 Sfikakis P.P....Tsokos G.C. (1993)
    983. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. (PubMed id 8216401)9 Merryman P.F....Abramson S.B. (1993)
    984. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients. (PubMed id 8268974)9 Cuadrado M.J....Santamaria M. (1993)
    985. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity. (PubMed id 7687924)9 Reiter Z. and Taylor M.W. (1993)
    986. Mitogenic signal transduction in T lymphocytes in microgravity. (PubMed id 8501396)9 Cogoli A....MA1ller O. (1993)
    987. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. (PubMed id 8344700)9 Andersson U.G....Andersson J.P. (1993)
    988. DAB486IL-2 fusion toxin in refractory rheumatoid arthritis. (PubMed id 8216416)9 Sewell K.L....Trentham D.E. (1993)
    989. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. (PubMed id 8437006)9 Sharief M.K. and Thompson E.J. (1993)
    990. Bidirectional modulation of human B cell stimulation by activated T cells. (PubMed id 8370072)9 Hirohata S. and Shinohara S. (1993)
    991. 1992 Stohlman Memorial Lecture: targeting the IL-2 re ceptor. (PubMed id 8361223)9 Waldmann T.A. (1993)
    992. In vitro lymphocyte reactivity to heavy metal salts in the diagnosis of oral mucosal hypersensitivity to amalgam restorations. (PubMed id 8427819)9 Nordlind K. and Liden S. (1993)
    993. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. (PubMed id 8228801)9 Fluckiger A.C....Banchereau J. (1993)
    994. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. (PubMed id 8242620)9 Whiteside T.L....Herberman R.B. (1993)
    995. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. (PubMed id 8105989)9 Anderson J.T....Peck A.B. (1993)
    996. Leflunomide, a novel immunosuppressive agent. The mec hanism of inhibition of T cell proliferation. (PubMed id 8390735)9 Chong A.S....Williams J.W. (1993)
    997. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. (PubMed id 8266077)9 Noguchi M....Leonard W.J. (1993)
    998. Inhibition of human T cell response to staphylococcal enterotoxin B by prior ligation of surface CD4 molecules. (PubMed id 8102087)9 Fournel S....Bonnefoy-Berard N. (1993)
    999. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. (PubMed id 8214299)9 Wanebo H.J....Mehta S. (1993)
    1000. The in vitro senescence of human T lymphocytes: failure to divide is not associated with a loss of cytolytic activity or memory T cell phenotype. (PubMed id 8469029)9 Perillo N.L....Effros R.B. (1993)
    1001. Tumour growth inhibition in mice by glycosylated recombinant human lymphotoxin: analysis of tumour-regional mononuclear cells involved with its action. (PubMed id 8439496)9 Funahashi I....Miyaji H. (1993)
    1002. Experimental modulation of IL-1 production and cell surface molecule expression by levamisole. (PubMed id 8103313)9 Kimball E.S. (1993)
    1003. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. (PubMed id 8448682)9 Walker C....WA1thrich B. (1993)
    1004. Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin. (PubMed id 8428390)9 Nicoletti F....Magro G. (1993)
    1005. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. (PubMed id 8406577)9 Zhang Y.H....Nakashima I. (1993)
    1006. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft. (PubMed id 8417059)9 Fyfe A....Cardella C. (1993)
    1007. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE. (PubMed id 8485565)9 Wallace D.J....Stecher V.J. (1993)
    1008. Exogenous glutamine requirement is confined to late events of T cell activation. (PubMed id 7905486)9 HAPrig H....Heberer M. (1993)
    1009. The synergistic effects of interleukin 2 and interleukin 7 on the proliferation and autologous tumor cell lysis of tumor-associated lymphocytes. (PubMed id 8292458)9 Tsukuda M....Yanoma S. (1993)
    1010. Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number. (PubMed id 8101978)9 Stachowski J....Baldamus C.A. (1993)
    1011. Elevation of soluble IL-2 receptor and IL-4, and nonelevation of IFN-gamma in sera from patients with allergic asthma. (PubMed id 8250351)9 Hashimoto S....Horie T. (1993)
    1012. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. (PubMed id 8138825)9 Ott M....Fischer P.A. (1993)
    1013. Modulation of biological responses of normal human mononuclear cells by antiestrogens. (PubMed id 8476225)9 Teodorczyk-Injeyan J....Kellen J.A. (1993)
    1014. Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias. (PubMed id 8393431)9 Plate J.M....Gregory S.A. (1993)
    1015. The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. (PubMed id 8384218)9 Merida I....Gaulton G.N. (1993)
    1016. Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. (PubMed id 8395442)9 Morshed S.A....Nishioka M. (1993)
    1017. Retinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitis. (PubMed id 7511004)9 Liversidge J....Forrester J.V. (1993)
    1018. The role of cytokines in the pathophysiology of chronic liver diseases. (PubMed id 8123873)9 Tilg H. (1993)
    1019. Expression of human IL-2 receptor alpha- and beta-chains using the baculovirus expression system. (PubMed id 8356402)9 Lindqvist C....Oker-Blom C. (1993)
    1020. [Ultradian variations of interleukin-1 beta concentration (IL-1 beta), interferon gamma (IFN-gamma) and soluble IL-2 receptors (RIL-2) in healthy volunteers humen] (PubMed id 8019924)9 Bouayad-Amine D....Serrou B. (1993)
    1021. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro. (PubMed id 8095271)9 Giordano C....Galluzzo A. (1993)
    1022. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects. (PubMed id 8301059)9 Tilg H....Schwulera U. (1993)
    1023. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells. (PubMed id 8431210)9 Sfikakis P.P....Panayiotidis P.P. (1993)
    1024. Regulation of lymphocyte function by protein phosphorylation. (PubMed id 8476569)9 Perlmutter R.M....Alberola-Ila J. (1993)
    1025. Cytokine gene expression in skin and lymphoid organs in graft versus host disease. (PubMed id 8496391)9 Rowbottom A.W....Sloane J.P. (1993)
    1026. Interleukin-2 receptor signal transduction: translocation of active serine-threonine kinase Raf-1 from IL-2 receptor into cytosol depends on IL-2-induced tyrosine kinase activation. (PubMed id 8438242)9 Maslinski W....Strom T.B. (1993)
    1027. Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. (PubMed id 8358720)9 LeMaistre C.F....Woodworth T. (1993)
    1028. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. (PubMed id 8370444)9 Fireman E....Greif J. (1993)
    1029. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma] (PubMed id 8334935)9 Duan Z.F. (1993)
    1030. Inhibition of anti-CD3 monoclonal antibody-induced T- cell proliferation and interleukin-2 secretion by physiologic combinations of d examethasone and prostaglandin E2. (PubMed id 7910781)9 Elliott L....Roszman T. (1993)
    1031. Interleukin-4 induces proliferation of adult T-cell leukemia cells. (PubMed id 8472809)9 Mori N....Eto S. (1993)
    1032. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC. (PubMed id 8320080)9 Mikhail N....Degiannis D. (1993)
    1033. Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. (PubMed id 7509146)9 Morikawa K....Sawada M. (1993)
    1034. Augmentation of lymphokine-activated killer cell activity by lentinan. (PubMed id 8267381)9 Tani M....Mizobata S. (1993)
    1035. Signal transduction defect in the acquired immunodeficiency syndrome and AIDS-related complex. (PubMed id 8209399)9 Gupta S. (1993)
    1036. The effects of auranofin on activation and interleukin-2 release from human peripheral blood mononuclear cells. (PubMed id 8023745)9 Vint I.A....Foreman J.C. (1993)
    1037. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. (PubMed id 8319179)9 Baxevanis C.N....Papamichail M. (1993)
    1038. Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma. (PubMed id 8471836)9 Castello G....Comella G. (1993)
    1039. The chimeric receptor between interleukin-2 receptor beta chain and interleukin-4 receptor transduces interleukin-2 signal. (PubMed id 7679903)9 Izuhara K....Harada N. (1993)
    1040. IL-2 receptor gene expression and IL-2 production by human preterm newborns' cells. (PubMed id 8370178)9 Bessler H....Djaldetti M. (1993)
    1041. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor. (PubMed id 8260648)9 Cantrell D.A....Woodrow M. (1993)
    1042. Inhibition of human mononuclear cell proliferation, interleukin synthesis, mRNA for IL-2, IL-6, and leukotriene B4 synthesis by a lipoxygenase inhibitor. (PubMed id 8409748)9 Atluru D....Woloschak G.E. (1993)
    1043. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. (PubMed id 8450329)9 Mathiesen T....von Holst H. (1993)
    1044. Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor beta subunit (beta IL3). (PubMed id 8340408)9 Sakamaki K....Miyajima A. (1993)
    1045. Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients. (PubMed id 1296454)9 Lissoni P....Maestroni G.J. (1992)
    1046. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. (PubMed id 1347306)9 van Vlasselaer Vries J.E. (1992)
    1047. Modulation of human T cell functions by surface sulphydryl groups: differential effects on IL-2 production and responsiveness. (PubMed id 1563102)9 Smith S....Hall N.D. (1992)
    1048. The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. (PubMed id 1281561)9 Morikawa K....Morikawa S. (1992)
    1049. The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2. (PubMed id 1511461)9 Carter C.R....Rees R.C. (1992)
    1050. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer. (PubMed id 1739919)9 Shimizu Y....Masubuchi K. (1992)
    1051. Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes. (PubMed id 1321793)9 StankovA! J....Rola-Pleszczynski M. (1992)
    1052. Elevation of activated gamma delta T cell receptor be aring T lymphocytes in patients with autoimmune chronic liver disease. (PubMed id 1385768)9 Wen L....Vergani D. (1992)
    1053. [Changes in LAK cell activity in chronic viral hepatitis and treatment with autologous LAK cell transfusion] (PubMed id 1478122)9 Si C.W....Yu M. (1992)
    1054. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. (PubMed id 1731582)9 MA1ller-Quernheim J....Ferlinz R. (1992)
    1055. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate -affinity IL-2 receptor complex. (PubMed id 1545122)9 Takeshita T....Sugamura K. (1992)
    1056. The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells. (PubMed id 1380951)9 Friccius H....Pawelec G. (1992)
    1057. Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes. (PubMed id 1534515)9 Ioannides C.G....Freedman R.S. (1992)
    1058. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. (PubMed id 1535088)9 Rabinowich H....Whiteside T.L. (1992)
    1059. Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. (PubMed id 1644922)9 Harpaz R....Sztein M.B. (1992)
    1060. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells. (PubMed id 1472476)9 Mills G.B....Greene W.C. (1992)
    1061. Structural requirements for the modulatory effect of 6-substituted pterins on interleukin 2 receptor binding. (PubMed id 1535794)9 Ziegler I....Boyle P.H. (1992)
    1062. Electron microscopic observation of killer cells indu ced by mixed culture of lymphocytes with autologous cancer cells and further cu lture with recombinant interleukin-2. (PubMed id 1489283)9 Murakami H....Kanda T. (1992)
    1063. The correlation between interleukin 2 and soluble interleukin 2 receptors to oestradiol, progesterone and testosterone levels in periovulatory follicles of in-vitro fertilization patients. (PubMed id 1430130)9 Barak V....Laufer N. (1992)
    1064. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. (PubMed id 1322203)9 Pang Y....Young H.A. (1992)
    1065. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV. (PubMed id 1735193)9 Noronha I.L....Opelz G. (1992)
    1066. Defect in generation of LAK cell activity under oxygen-limited conditions. (PubMed id 1500092)9 Ishizaka S....Tsujii T. (1992)
    1067. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage. (PubMed id 1394062)9 Szeimies R.M....Kaudewitz P. (1992)
    1068. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. (PubMed id 1582055)9 Mandreoli M....Zucchelli P. (1992)
    1069. The mechanism of action of serum immunosuppressive factor in Crohn's disease: it blocks the growth of mitogen-stimulated lymphocytes in early G1 phase through an inhibition of transferrin receptor expression. (PubMed id 1343345)9 Iwao Y....Toda K. (1992)
    1070. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. (PubMed id 1571256)9 Czech W....Kapp A. (1992)
    1071. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis. (PubMed id 1301961)9 Manoussakis M.N....Moutsopoulos H.M. (1992)
    1072. Inhibitory effect by 1,25-dihydroxyvitamin D3 on conc anavalin A-stimulated proliferation of rat thymic lymphocytes. (PubMed id 1477603)9 Kojima A....Morii H. (1992)
    1073. Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cells. (PubMed id 1405755)9 Sahraoui Y....Georgoulias V. (1992)
    1074. Mechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptor. (PubMed id 1624223)9 Chang M.P....Norman D.C. (1992)
    1075. TCR gamma/delta positive lymphocytes after allogeneic bone marrow transplantation. (PubMed id 1422478)9 Viale M....Bacigalupo A. (1992)
    1076. [Intrathecal immune response in meningeosis neoplastica: IgG, IgM, oligoclonal bands and cytokines] (PubMed id 1594086)9 Weller M....WiethAPlter H. (1992)
    1077. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. (PubMed id 1284103)9 WA1thrich B....Joller-Jemelka H. (1992)
    1078. Cytometrically detected specific binding of interleuk in 2 to cells. (PubMed id 1498254)9 Bergmann C.A....Kaplan D.R. (1992)
    1079. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients. (PubMed id 1730139)9 Whitford P....Campbell A.M. (1992)
    1080. The multichain interleukin-2 receptor: a target for immunotherapy. (PubMed id 1727619)9 Waldmann T.A....Junghans R.P. (1992)
    1081. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. (PubMed id 1549569)9 Wucherpfennig K.W....Hafler D.A. (1992)
    1082. Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin. (PubMed id 1479097)9 van Joost T....Prens E.P. (1992)
    1083. Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. (PubMed id 1606722)9 Prummel M.F....Koornneef L. (1992)
    1084. Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaema gglutinin. (PubMed id 1356669)9 Leung J.C....Lai K.N. (1992)
    1085. Decreased interleukin-2 beta-chain receptor expression by interleukin-4 on LGL: influence on the IL-2 induced cytotoxicity and proliferation. (PubMed id 1596876)9 Lindqvist C....Akerman K. (1992)
    1086. Phenotype, activation and lymphokine secretion by gamma/delta T lymphocytes from schistosomiasis and carcinoma of the urinary bladder. (PubMed id 1531634)9 Raziuddin S....Ibrahim A. (1992)
    1087. Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms. (PubMed id 1511722)9 Abbate I....Cramarossa A. (1992)
    1088. [Large granular lymphocytic leukemia] (PubMed id 1518140)9 Tagawa S....Kitani T. (1992)
    1089. Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes. (PubMed id 1615582)9 Ditonno P....Belldegrun A. (1992)
    1090. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. (PubMed id 1421636)9 KAogi M.K....WA1thrich B. (1992)
    1091. Cytokine inter-relationships and their association with disease activity in arthritis. (PubMed id 1304740)9 Holt I....Hopkins S.J. (1992)
    1092. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein). (PubMed id 1737371)9 List J....Grimm E.A. (1992)
    1093. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. (PubMed id 1376654)9 Bass H.Z....Fahey J.L. (1992)
    1094. Distribution of IL-2R and CD45Ro expression on CD4+ and CD8+ T-lymphocytes in the peripheral blood of patients with posterior uveitis. (PubMed id 1358556)9 Feron E.J....Lightman S.L. (1992)
    1095. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. (PubMed id 1733089)9 Lipman M.L....Strom T.B. (1992)
    1096. T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction. (PubMed id 1457964)9 Schmandt R....Mills G.B. (1992)
    1097. Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations. (PubMed id 1411093)9 MA1ller K....Bendtzen K. (1992)
    1098. [OK-432-induced cytokines production by peripheral blood mononuclear cells] (PubMed id 1307613)9 Ono M....Itoh C. (1992)
    1099. Potentiation of IL-2-induced t-cell proliferation by retinoids. (PubMed id 1624219)9 Jiang X.L....Lamon E.W. (1992)
    1100. Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. (PubMed id 1374550)9 Smith M.D....Roberts-Thomson P.J. (1992)
    1101. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia] (PubMed id 1575640)9 Tada S....Tanizaki K. (1992)
    1102. Okadaic acid enhances human T cell activation and phosphorylation of an internal substrate induced by phorbol myristate acetate. (PubMed id 1333455)9 Tada Y....Niho Y. (1992)
    1103. Phenotypic changes induced by interleukin-2 (IL-2) and IL-3 in an immature T-lymphocytic leukemia are associated with regulated expression of IL-2 receptor beta chain and of protein tyrosine kinases LCK and LYN. (PubMed id 1379847)9 O'Connor R....Santoli D. (1992)
    1104. A VLA-4 alpha-chain specific monoclonal antibody enha nces CD3-induced IL-2/IL-2 receptor-dependent T-cell proliferation. (PubMed id 1467362)9 Udagawa T. and McIntyre B.W. (1992)
    1105. Cutaneous pleomorphic large cell lymphoma. (PubMed id 1424797)9 von den Driesch P....Hornstein O.P. (1992)
    1106. Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. (PubMed id 1424290)9 Rostoker G....Weil B. (1992)
    1107. Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients. (PubMed id 1292506)9 Lissoni P....Tancini G. (1992)
    1108. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. (PubMed id 1740278)9 Brynskov J....Vilien M. (1992)
    1109. Prophylactic use of the IL-2 receptor-specific monocl onal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantatio n. (PubMed id 14621841)9 Hiesse C....Bazin H. (1992)
    1110. Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis model. (PubMed id 1600120)9 Donati D....Raska K. (1992)
    1111. Immunologic effector cells in head and neck cancer. (PubMed id 1356393)9 Vitolo D....Whiteside T.L. (1992)
    1112. Biocompatibility of high-flux membranes. (PubMed id 1399092)9 Putz D....Graf H. (1992)
    1113. [Analysis of tumor-infiltrating lymphocyte in primary malignant lymphoma of the central nervous system using double immunofluorescence staining method] (PubMed id 1533133)9 Kunishio K....Nishimoto A. (1992)
    1114. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations. (PubMed id 1639222)9 SchA1rmann G....Meuer S. (1992)
    1115. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities. (PubMed id 1381742)9 Ortaldo J.R....Bach F.H. (1992)
    1116. The IL-2/IL-2 receptor system: involvement of a novel receptor subunit, gamma chain, in growth signal transduction. (PubMed id 1306308)9 Sugamura K....Nakamura M. (1992)
    1117. Inhibitory effect of human syncytiotrophoblast plasma membrane vesicles on Jurkat cells activated by phorbol ester and calcium ionophore. (PubMed id 1309491)9 Thibault G....Bardos P. (1992)
    1118. Characterization of HTLV-I in vivo infected T cell cl ones. IL-2-independent growth of nontransformed T cells. (PubMed id 1374452)9 HAPllsberg P....Hafler D.A. (1992)
    1119. Cytokine production and serum levels in systemic sclerosis. (PubMed id 1451330)9 Kantor T.V....Whiteside T.L. (1992)
    1120. [Analysis of lymphocyte surface markers in childhood acute lymphoblastic leukemia during maintenance chemotherapy] (PubMed id 1580639)9 Sugita K....Furukawa T. (1992)
    1121. IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs. (PubMed id 1356854)9 Watson J....Sturrock R. (1992)
    1122. Tumour necrosis factor receptor distribution in human lymphoid tissue. (PubMed id 1663076)9 Ryffel B....Gudat F. (1991)
    1123. Cytokine levels during hemodialysis. (PubMed id 1751202)9 Vaziri N.D....Cesario T.C. (1991)
    1124. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway. (PubMed id 1825060)9 Ruggiero G....Fontana S. (1991)
    1125. Growth of certain myeloid leukemic cells can be stimulated by interleukin-2. (PubMed id 1777232)9 Tanaka M. (1991)
    1126. Therapeutic benefits of calcium channel blockers in c yclosporine-treated organ transplant recipients: blood pressure control and imm unosuppression. (PubMed id 2039018)9 Weir M.R. (1991)
    1127. Additive inhibition of afferent and efferent immunolo gical responses of human peripheral blood mononuclear cells by verapamil and cy closporine. (PubMed id 2014542)9 Weir M.R....Handwerger B.S. (1991)
    1128. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. (PubMed id 1716974)9 Nishikawa K....Sugamura K. (1991)
    1129. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels. (PubMed id 2056069)9 Trotter J.L....van der Veen R.C. (1991)
    1130. Determination of interleukin 2 receptor number of Con A stimulated human lymphocytes with aging. (PubMed id 1667939)9 FA1lAPp T....Hirokawa K. (1991)
    1131. In situ immunophenotype of macrophages and lymphocytes in granuloma formation of tuberculous lymphadenitis in HIV-infected and immunocompetent patients. (PubMed id 1896641)9 MA1ller H. and Takeshita M. (1991)
    1132. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. (PubMed id 1914259)9 Ward B.J....Griffin D.E. (1991)
    1133. A critical review of immunosuppressive therapy. (PubMed id 1916932)9 Briggs J.D. (1991)
    1134. The role of CD45RA on human B-cell function: anti-CD45RA antibody (anti-2H4) inhibits the activation of resting B cells and antibody production of activated B cells independently in humans. (PubMed id 1715602)9 Morikawa K....Morikawa S. (1991)
    1135. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation. (PubMed id 2017664)9 Hashimoto S....Michalski J.P. (1991)
    1136. Suppressive activity of interleukin 4 on the induction of antigen-specific cytotoxic T cells in humans. (PubMed id 1712006)9 Yamashita U. and Tanaka Y. (1991)
    1137. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. (PubMed id 1827837)9 Gallo P....SidAcn A. (1991)
    1138. The role of the transferrin receptor for the activation of human lymphocytes. (PubMed id 1988160)9 Keyna U....Manger B. (1991)
    1139. Modulation of interleukin 2 internalization and inter leukin 2-dependent cell growth by antireceptor antibodies. (PubMed id 1988432)9 Duprez V....Dautry-Varsat A. (1991)
    1140. Blood lymphocyte proliferation, cytokine secretion an d appearance of T cells with activation surface markers in cultures with Helico bacter pylori. Comparison of the responses of subjects with and without antibod ies to H. pylori. (PubMed id 1900743)9 Karttunen R. (1991)
    1141. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. (PubMed id 1871801)9 Kunzendorf U....Strom T.B. (1991)
    1142. [Serum soluble IL-2 receptor level in patients with sarcoidosis] (PubMed id 2067152)9 Ina Y....Yamamoto M. (1991)
    1143. Detection, isolation and functional studies of CD25+ T cells in lymph nodes involved by B-cell non-Hodgkin's lymphomas. (PubMed id 2068535)9 Bonnefoix T....Sotto J.J. (1991)
    1144. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility. (PubMed id 1985276)9 Peter J.B....Tourtellotte W.W. (1991)
    1145. The role of endogenous opioids and their receptors in the immune system. (PubMed id 1656470)9 Carr D.J. (1991)
    1146. Modulating effects on CD25 and CD71 antigen expression by lectin-stimulated T lymphocytes in the elderly. (PubMed id 1770220)9 Antonaci S....Bonomo L. (1991)
    1147. Cocaine immunotoxicity: abnormal cytokine production in Hispanic drug users. (PubMed id 1721732)9 Chen G.J....Watson R.R. (1991)
    1148. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients. (PubMed id 1781183)9 Choi I.H....Kim S.J. (1991)
    1149. Therapy of advanced acute myeloblastic leukemia with cytarabine and interleukin 2. (PubMed id 1910127)9 Butturini A....Castriota Scanderbeg A. (1991)
    1150. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses. (PubMed id 1984478)9 Salkind A.R....Roberts N.J. (1991)
    1151. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. (PubMed id 1652056)9 Augustine J.A....Abraham R.T. (1991)
    1152. Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3. (PubMed id 2070147)9 Anasetti C....Stewart P. (1991)
    1153. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. (PubMed id 1835714)9 Radrizzani M....Fossati G. (1991)
    1154. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. (PubMed id 1679332)9 Kay T.W....Harrison L.C. (1991)
    1155. T-cell activation. IV. Evidence for a functional linkage between MHC class I, interleukin-2 receptor, and interleukin-4 receptor molecules. (PubMed id 1832052)9 Hansen N.Q....Claesson M.H. (1991)
    1156. Human CD4+CD45R0+ and CD4+CD45RA+ T cells synergize in response to alloantigens. (PubMed id 1680701)9 Akbar A.N....Janossy G. (1991)
    1157. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide deple tion. (PubMed id 1826793)9 Eugui E.M....Allison A.C. (1991)
    1158. Purification and characterization of the immunostimulatory properties of recombinant human interleukin-1 beta. (PubMed id 1873490)9 Ketlinsky S....Perumov N.D. (1991)
    1159. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. (PubMed id 1939640)9 Kurane I....Ennis F.A. (1991)
    1160. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. (PubMed id 1934593)9 North M.E....Farrant J. (1991)
    1161. FK506 lacks the ability to inhibit expression of inte rleukin-2 receptor beta-chain on human lymphocytes. (PubMed id 1726895)9 Karlsson H. and NAossberger L. (1991)
    1162. Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. (PubMed id 1654606)9 Furue M. and Ishibashi Y. (1991)
    1163. Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A. (PubMed id 1864013)9 Yoshimura N....Imanishi J. (1991)
    1164. Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency. (PubMed id 1934612)9 Waldmann T.A. (1991)
    1165. [Immunological study on renal cell carcinoma in dialysis patients with acquired cystic disease of kidneys] (PubMed id 1762269)9 Onishi T....Makino H. (1991)
    1166. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. (PubMed id 1676547)9 Carabasi M.H....Dupont B. (1991)
    1167. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia. (PubMed id 2072745)9 Cimino G....Mandelli F. (1991)
    1168. Interleukin-4 downregulates the p70 chain of the IL-2 receptor on peripheral blood mononuclear cells. (PubMed id 2060024)9 Lindqvist C....Andersson L.C. (1991)
    1169. Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. (PubMed id 1832993)9 Massaia M....Pileri A. (1991)
    1170. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. (PubMed id 1940975)9 Weller M....WiethAPlter H. (1991)
    1171. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. (PubMed id 2370014)9 Brynskov J. and Tvede N. (1990)
    1172. Interaction between endogenous opioids and IL-2 on PH A-stimulated human lymphocytes. (PubMed id 2394465)9 Kay N.E....Allen J.I. (1990)
    1173. Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms. (PubMed id 2119791)9 Pizzolo G....Diamantstein T. (1990)
    1174. Immune activation markers to predict AIDS and survival in HIV-1 seropositives. (PubMed id 2125976)9 Fuchs D....Wachter H. (1990)
    1175. Interleukin-2 receptor expression and interleukin-2 p roduction in bullous pemphigoid. (PubMed id 1973607)9 Schaller J....Haustein U.F. (1990)
    1176. Bronchoalveolar T-lymphocytes and subsets in pulmonary tuberculosis and bronchogenic carcinoma. (PubMed id 2345320)9 Pushpakom R....Bovornkitti S. (1990)
    1177. Activation of human CD8-positive T cells via the CD8/ HLA class I complex. (PubMed id 2105853)9 Bushkin Y....Le J.M. (1990)
    1178. Monoclonal antibodies and arthritis. (PubMed id 2327319)9 Billingham M.E....Carney S. (1990)
    1179. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. (PubMed id 1969960)9 Prince H.E....Williams A.E. (1990)
    1180. [Detection of the activation of alveolar lymphocytes in alveolar proteinosis] (PubMed id 2367399)9 Teschler H....Costabel U. (1990)
    1181. Human blood basophils synthesize interleukin-2 binding sites. (PubMed id 1691935)9 Stockinger H....Knapp W. (1990)
    1182. T cell activation. II. Activation of human T lymphoma cells by cross-linking of their MHC class I antigens. (PubMed id 2137376)9 Dissing S....Claesson M.H. (1990)
    1183. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. (PubMed id 2380552)9 Karray S....Galanaud P. (1990)
    1184. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. (PubMed id 1976464)9 Matsubayashi S....VolpAc R. (1990)
    1185. T cell responses in acute falciparum malaria. (PubMed id 2283144)9 Ho M. and Webster H.K. (1990)
    1186. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. (PubMed id 1970938)9 Soiffer R.J....Ritz J. (1990)
    1187. Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes. (PubMed id 2110548)9 Rodriguez M.A....Abadi I. (1990)
    1188. A monoclonal mouse anti-human IL-2 receptor antibody (anti-Tac) will recognize molecules on the surface of Xenopus laevis immunocytes which specifically bind rIL-2 and are only slightly larger than the human Tac protein. (PubMed id 2354864)9 Ruben L.N....Shiigi S. (1990)
    1189. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. (PubMed id 1700727)9 Richards J.M....Golomb H.M. (1990)
    1190. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding. (PubMed id 2105168)9 Rigby W.F....Waugh M.G. (1990)
    1191. Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4 positive lymphocytes. (PubMed id 1967955)9 Tosato G....Pike S.E. (1990)
    1192. IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells. (PubMed id 2212661)9 Kozak R.W....Pastan I. (1990)
    1193. The effect of desferrithiocin, an oral iron chelator, on T-cell function. (PubMed id 2242426)9 Bierer B.E. and Nathan D.G. (1990)
    1194. Purification of soluble cytokine receptors from norma l human urine by ligand-affinity and immunoaffinity chromatography. (PubMed id 2144854)9 Novick D....Rubinstein M. (1990)
    1195. CD4+ CD45R- suppressor-inducer T-cell clones: requirements for cellular interaction, proliferation and lymphokines for the induction of suppression in peripheral blood mononuclear cells. (PubMed id 1692302)9 Pawelec G. (1990)
    1196. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? (PubMed id 2118691)9 Meliconi R....Gasbarrini G. (1990)
    1197. Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease. (PubMed id 2328206)9 Damle R.N....Gangal S.G. (1990)
    1198. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. (PubMed id 1968925)9 Martinez O.M....Aronson F.R. (1990)
    1199. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. (PubMed id 1975810)9 Lorberboum-Galski H....Pastan I. (1990)
    1200. Levamisole meets sulfhydryl requirements of CTLL-2 ce lls and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production. (PubMed id 2380743)9 Obiri N.I....O'Connor T.E. (1990)
    1201. CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHA. (PubMed id 2118015)9 Katagiri K....Yoshida T. (1990)
    1202. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors. (PubMed id 2365829)9 Elliott L.H....Roszman T.L. (1990)
    1203. Interleukin-2 immunotherapy in children. (PubMed id 2174536)9 Chien C.H. and Hsieh K.H. (1990)
    1204. The biological significance of soluble interleukin-2 receptors in solid tumors. (PubMed id 2138475)9 Lissoni P....Tancini G. (1990)
    1205. [Receptor-mediated cancer therapy--tumoricidal cytokines, adoptive therapy of LAK, TIL] (PubMed id 1693487)9 Niitsu Y....Kanisawa Y. (1990)
    1206. [The effect of heat shock on mRNA expression in human T lymphocytes] (PubMed id 2151259)9 Liu Z. (1990)
    1207. Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha. (PubMed id 2160321)9 Yang S.C....Grimm E.A. (1990)
    1208. Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models. (PubMed id 2225311)9 Bacha P....Rosenblum M. (1990)
    1209. Immunologic effects of AS101 in the treatment of cancer patients. (PubMed id 2370878)9 Shani A....Michlin H. (1990)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section
    Free Text  

      Query String
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section
    Entrez Gene: 3560 HGNC: 6009 AceView: IL2RBandC1QTNF6 Ensembl:ENSG00000100385 euGenes: HUgn3560
    ECgene: IL2RB Kegg: 3560 H-InvDB: IL2RB

    (According to HUGE)
    About This Section

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section
    PharmGKB entry for IL2RB Pharmacogenomics, SNPs, Pathways
    ATLAS Chromosomes in Cancer entry for IL2RB Genetics and Cytogenetics in Oncology and Haematology

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section
    Patent Information for IL2RB gene:
    Search GeneIP for patents involving IL2RB

    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search

    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Cloud-Clone Corp., Thermo Fisher Scientific, LSBio, Gene Editing from DNA2.0 and Sirion Biotech, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Sirion Biotech, Cell lines from GenScript, and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or Enzo Life Sciences, In Situ Hybridization Assays from
    Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory, genOway)
    About This Section

     EMD Millipore Custom Antibody & Bulk Services
     EMD Millipore Preclinical / Clinical Development Services
     EMD Millipore Immunoassay Services
     EMD Millipore Target Screening & Profiling Services

     Antibodies for IL2RB (IL-2 R beta)   Browse Cell Culture Products  
     Browse ELISAs   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Kinase Activity Assays/Reagents  
     Browse ELISpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Multiplex/Array Assay Kits/Reagents  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Protease Activity Assays and Reagents   Recombinant/Natural Proteins for IL2RB (IL-2 R beta)  
     Browse Stem Cell Products   Browse Tocris Biochemicals & Compounds  
     Browse cDNA Clones   Proteome Profiler Antibody Arrays for IL2RB (IL-2 R beta)  
     Browse OriGene Antibodies   OriGene RNAi products in human, mouse, rat for IL2RB  
     OriGene qPCR primer pairs and template standards for IL2RB   OriGene Protein Over-expression Lysate for IL2RB  
     OriGene Custom Mass Spec   OriGene clones in human, mouse for IL2RB  
     OriGene qSTAR qPCR primer pairs in human, mouse for IL2RB   Browse OriGene full length recombinant human proteins expressed in human HEK293 cells  
     OriGene ORF clones in mouse, rat for IL2RB   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for IL2RB   OriGene Custom Protein Services for IL2RB  

     QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat IL2RB
     QIAGEN SeqTarget long-range PCR primers for resequencing IL2RB
     QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat IL2RB
     QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat IL2RB
     QIAGEN QuantiFast Probe-based Assays in human, mouse, rat IL2RB
     QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat IL2RB
     GenScript Custom Purified and Recombinant Proteins Services for IL2RB GenScript cDNA clones with any tag delivered in your preferred vector for IL2RB
     GenScript Custom Assay Services for IL2RB GenScript Custom Superior Antibodies Services for IL2RB
     GenScript Custom overexpressing Cell Line Services for IL2RB CloneReady with Over 120,000 Genes
     Gene Synthesis: Any Gene in Any Vector Vector-based siRNA and miRNA, Ready for Transfection
     Gene Mutant Library, Variants up to 10^11 Plasmid Preparation
     Custom Peptide Services
     Antibodies & Assays for IL2RB 

     Regulatory tfbs in IL2RB promoter
     Search Chromatin IP Primers for IL2RB
     RT2 qPCR Primer Assay in human, mouse, rat IL2RB
     GNC Network for IL2RB
     SABiosciences PCR Arrays including human, mouse, rat IL2RB
     Search Tocris compounds for IL2RB
     Proteins and Antibodies for IL2RB
     Cell Lysates for IL2RB
     cDNA Clones for IL2RB
     4000+ Proteins
     Search Sino Biological for antibodies, proteins & pathways
     Protein Production Services
     Transfection Reagents
     Protein A/G/L resins
     Isotyping reagents
     Search for proteins, assays, substrates, inhibitors & antibodies
     Novus Tissue Slides
     IL2RB antibodies
     IL2RB proteins
     IL2RB lysates
     Antibodies for IL2RB
     See all of Abcam's Antibodies, Kits and Proteins for IL2RB
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Browse ProSpec Recombinant Proteins

     Browse Proteins at Cloud-Clone Corp.
     Browse Antibodies at Cloud-Clone Corp.
     Browse ELISAs at Cloud-Clone Corp.
     Browse CLIAs at Cloud-Clone Corp.
     Search LifeMap BioReagents cell lines for IL2RB
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IL2RB
     SwitchGear 3'UTR luciferase reporter plasmids for IL2RB
     SwitchGear Promoter luciferase reporter plasmids for IL2RB
     ThermoFisher Antibodies for IL2RB
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IL2RB
     inGenious Targeting Laboratory - Custom generated mouse model solutions for IL2RB
     inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for IL2RB
     lentivirus for stable overexpression of IL2RB
     lentivirus expression plasmids for stable overexpression of IL2RB
     adenovirus for overexpression of IL2RB
     LSBio Antibodies in human, mouse, rat for IL2RB
    Customized transgenic rodents for:
     Biomarker expression
     Off-target effect monitoring
     Translational medicine
     Tissue-specific gene expresssion
     Time-controlled gene expresssion
    GeneCards Homepage - Last full update: 23 Oct 2013 - Incrementals: 3 Nov 2013 , 7 Nov 2013 , 23 Jan 2014

    View Random Gene

    (GIFtS: 73)
    transforming growth factor, beta 1
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 

    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      IL2RB gene at Home site.
    hostname: index build: 106 solr: 1.4